← Back

Clinical Pathophysiology I · Exam 2 — Study Guide

PAJ 5101 Clinical Pathophysiology I · Class of 2028 · Exam 2 is Wednesday 18 November 2026 (Lectures 6–10)

Covers Lecture 6, Cardiac Pathophysiology; Lecture 7, Vascular Pathophysiology; Lecture 8, Immunity; Lecture 9, Pulmonary Pathophysiology; and Lecture 10, Pathophysiology of Blood Disorders · Instructional Objectives (IOs) taken verbatim from the syllabus · mechanism throughout, not management

6 · Cardiac Pathophysiology

Lecture 6 · 14 September 2026 · deck title slide: “Lecture Prepared by: Matthew Ward, DMSc, MBA, PA-C”. The calendar lists Dr. Rappa for this session; who delivered it is not confirmed.

Instructional Objectives

  1. Review the anatomy of the heart
  2. Review the function of cardiac structures
  3. Review the different lipoproteins
  4. Describe the molecular mechanisms of common cardiopathies
  5. Compare and contrast the various etiologies and risk factors for coronary heart disease
  6. Describe the pathological processes and risk factors for the formation of coronary atherosclerosis and plaques
  7. Explain the pathophysiology of cardiac ischemia
  8. Compare and contrast the etiologies and pathophysiological processes of coronary syndromes
  9. Describe the etiologies and pathophysiological processes for angina pectoris
  10. Compare and contrast the etiologies and pathophysiological processes of acute coronary syndrome
  11. Compare and contrast the etiologies and pathophysiological processes of valvular stenosis, regurgitation, and prolapse
  12. Compare and contrast the etiologies and pathophysiological processes of infective cardiopathies
  13. Compare and contrast the pathophysiology of blood pressure regulation
  14. Compare and contrast the pathophysiology of the cardiac conduction system
  15. Compare and contrast the pathophysiology of structural cardiac pathologies
No recording of this lecture exists, so nothing in this section is marked as professor-emphasized. Every fact here comes off the slides, and with no signposting to go on, the fair plan is to study all fifteen objectives evenly.
The deck and the syllabus list different objectives. The deck’s own objectives slide has thirteen (a–m), ending with pericarditidies and myopathies. The syllabus has fifteen (a–o), and the list above is the syllabus verbatim. Two of the syllabus objectives have little or nothing behind them in this deck: (m) blood pressure regulation is taught in Lecture 7, slides 19–21 (section 7.5), and (n) the conduction system has no slide at all (section 6.13 collects what the deck does say about rhythm).

6.1 · Objectives a & b — Anatomy of the heart and function of cardiac structures

The anatomy in this deck is the coronary circulation, because every disease that follows is a problem of supply through it. Three slides (5–7) are pictures only:

VesselBranches shown on the slides
Left main coronary arteryDivides into the left anterior descending artery (the anterior interventricular branch, running in the anterior interventricular sulcus) and the circumflex branch
Right coronary arteryRuns in the coronary sulcus; gives the marginal branch and the posterior interventricular branch
Anterior view of the heart with the right and left coronary arteries and their branches labeled.
The two coronary arteries and the branches you need by name: left coronary, circumflex, anterior interventricular; right coronary, marginal, posterior interventricular. Section 6.9 puts percentages on these: nearly every infarct is in the left ventricular wall, and the left anterior descending territory is the commonest. Lecture 6 · Slide 6
Schematic of coronary anatomy labeled right coronary artery, left main, left anterior descending and left circumflex.
The same tree reduced to four labels: right coronary artery, left main, left anterior descending, left circumflex. Lecture 6 · Slide 7

Function: what sets the heart’s oxygen demand

Slide 31 names the four determinants of workload: heart rate, preload, afterload and contractility. An increase in any one of them increases the demand for oxygen. That list is the demand half of every ischemia question (section 6.6).

The Frank–Starling law (slide 62)

The more the ventricle fills during diastole, the greater the volume it ejects in the systole that follows; in a healthy heart the end-diastolic volume will equal the stroke volume. The force any single muscle fiber generates is proportional to its initial sarcomere length (preload), and that stretch is set by the end-diastolic volume. Maximal force comes at an initial sarcomere length of 2.6 micrometers, a length rarely exceeded in the normal heart.

The slide sits just before the dilated cardiomyopathy slide for a reason: a ventricle that dilates keeps stretching its fibers, and the law describes the benefit of stretch only up to a point. Section 6.14 picks this up.

6.2 · Objective c — The different lipoproteins

Plaques are made of lipid, and lipid travels in the blood bound to specific proteins. Which lipoprotein carries it changes the risk (slide 12):

LipoproteinRich inEffect on atherosclerosis risk
Low-density lipoprotein (LDL)CholesterolHighest risk
Very-low-density lipoprotein (VLDL)TriglyceridesIncreases risk
High-density lipoprotein (HDL)—Decreases risk: carries cholesterol back to the liver, clearing it away from plaque

Very low density lipoprotein versus low density lipoprotein. Very low density lipoprotein is high in triglycerides rather than cholesterol. Both raise risk, so the distinction is what each is carrying.

Familial hypercholesterolemia (slide 13) is a common single-gene form of genetic hyperlipidemia (too much fat in the blood), classically taught as the most common form. The defect is in the low-density lipoprotein receptor on liver cells, so the liver cannot remove cholesterol from the bloodstream. High-fat diets are the acquired counterpart listed on the same slide.

Lecture 7 adds a fourth name: lipoprotein(a), an altered form of low-density lipoprotein linked to coronary and cerebrovascular disease, whose risk is independent of total cholesterol (section 7.7).

6.3 · Objective d — Molecular mechanisms of common cardiopathies

The deck has no single slide for this objective; it is answered across the lecture. Every disease here reduces to one of four mechanisms:

WhereMechanismExamples in this lecture
Coronary arteriesOxygen supply falls below demandStable, variant and unstable angina; myocardial infarction
ValvesExtra pressure work (stenosis) or extra volume work (regurgitation)Mitral and aortic stenosis and regurgitation; prolapse
MyocardiumInflammation, dilation, hypertrophy or stiffening of the muscle itselfMyocarditis; dilated, hypertrophic, restrictive cardiomyopathy
PericardiumExternal compression or encasement that limits fillingEffusion and tamponade; constrictive pericarditis

Homocysteine (slide 11)

An intermediary amino acid formed in the conversion of methionine to cysteine, with primarily atherogenic and prothrombotic properties. The vascular injury it causes: intimal thickening, elastic lamina disruption, smooth muscle hypertrophy, marked platelet accumulation, and formation of a platelet-enriched occlusive thrombus.

The molecular picture of a plaque (slide 19)

Three-panel diagram: initiation of atherosclerosis, early lesion, and vulnerable plaque, with labeled cells and mediators.
Read top to bottom. (a) Initiation: atherogenic factors (low-density lipoprotein cholesterol, diabetes, hypertension, smoking) cause endothelial dysfunction; signals such as monocyte chemoattractant protein 1 (MCP-1, a chemical that attracts monocytes) and vascular cell adhesion molecule (VCAM, which lets monocytes stick to the lining) recruit monocytes, and vascular smooth muscle cells activate. (b) Early lesion: foam cells form the fatty streak, and growth factors such as PDGF (platelet-derived growth factor) drive smooth muscle migration and proliferation. (c) Vulnerable plaque: a thin fibrous cap (smooth muscle cells dying by apoptosis), a lipid core full of foam cells, intense inflammation at the shoulder, and collagenases, elastases and stromelysins degrading the cap until it ruptures. Lecture 6 · Slide 19

6.4 · Objective e — Etiologies and risk factors for coronary heart disease

Definition (slide 4). Coronary heart disease, also called ischemic heart disease or coronary artery disease, is the insufficient delivery of oxygenated blood to the myocardium because of atherosclerotic coronary arteries. About 50% of those who die of cardiovascular disease die of it. When the heart’s metabolic demand for oxygen exceeds the supply, the myocardium becomes ischemic; ischemia causes abnormal heart function and abnormal cardiac rhythms, and if prolonged, irreversible damage.

Etiology (slides 8–9)How it causes ischemia
Atherosclerosis — behind almost all coronary heart diseaseProgressive narrowing of the lumen, which predisposes to the processes that precipitate ischemia: thrombosis, coronary vasospasm, endothelial cell dysfunction
Abnormalities of the microcirculationAbnormal regulation of the small cardiac vessels by their endothelial cells, so control of the cardiac blood supply is abnormal
Uncommon: decreased oxygen content of bloodA respiratory cause; the arteries are open but the blood carries too little
Uncommon: poor perfusionHypotension or hypovolemia; too little pressure to drive flow

Uncommon causes of coronary heart disease. Reduced oxygen content of the blood, and poor perfusion: the vessel may be open, but the blood carries too little oxygen or arrives at too low a pressure.

Major risk factors (slide 10)Probable risk factors
Age · family history · abnormal lipids · cigarette smoking · hypertension · diabetes mellitus · obesityMale sex · homocysteine · high-sensitivity C-reactive protein
Lecture 7 lists the atherosclerosis risk factors again and adds that family history is a strong risk factor, classically taught as the most important of them (slide 24), and that C-reactive protein is now used in cardiovascular risk stratification. See section 7.7.

6.5 · Objective f — Formation of coronary atherosclerosis and plaques

The sequence on slides 14–16, in order:

  1. Injury to the endothelial cells starts it — from chronic hemodynamic wall stress, toxins, inflammation or hyperlipidemia.
  2. The injured endothelium becomes more permeable, and leukocytes are recruited.
  3. Low-density lipoprotein leaks through the endothelial wall, where cells and macrophages oxidize it.
  4. Oxidized lipid damages both the wall and the smooth muscle cells; more macrophages arrive and keep engulfing lipid.
  5. Lipid-filled macrophages become foam cells. Both kinds of macrophage release inflammatory mediators and growth factor, attracting more leukocytes and stimulating smooth muscle proliferation.
  6. Excess lipid and debris pool inside the wall to form the lipid core.
  7. Plaques with large lipid cores are fragile and rupture, exposing subendothelial proteins, which starts platelet aggregation and thrombus formation; thrombotic material can be incorporated, enlarging the plaque.
  8. Over time collagen and fibrin form a cap, which makes the plaque more stable.
  9. Plaques grow over years until they begin to occlude the lumen. At 75% occlusion, blood flow is compromised.

Injured endothelium. Once it becomes more permeable, leukocytes are recruited and low density lipoprotein leaks through to be oxidized.

Compromised flow in coronary plaques. Blood flow is described as compromised at seventy-five percent occlusion; it takes a great deal of narrowing before flow suffers, so plaques grow silently for years.

Diagram of a vessel wall with lettered steps a to f from activated platelet to plaque formation.
The same sequence in six lettered steps: (a) an activated platelet, (b) deposition of chemokines on the endothelium, (c) adhesion of monocytes, (d) monocytes migrate into the wall and transform into macrophages, (e) macrophages ingest low-density lipoprotein, (f) plaque formation. Lecture 6 · Slide 18

What makes a plaque rupture

Slide 16 lists what makes a plaque vulnerable to erosion or rupture: intra-plaque inflammation, a large core with a thin cap, superficial platelet aggregation, a ruptured cap, and severe stenosis. Slides 26–28 give the reasons:

  • Risk depends on the composition of the plaque and the mechanical stresses on it. A vulnerable plaque has a large necrotic core under a thin fibrous cap.
  • A triggering event of enough magnitude and duration compromises it — for example the shear force of blood flowing at high velocity through a severe stenosis.
  • The diseased wall may be rich in vasa vasorum capillaries. Their thin walls hemorrhage, depositing blood products and building pressure inside the plaque.

The consequence (slide 29): thrombosis, and emboli carried downstream to block smaller vessels.

Histologic cross-section of a coronary artery with a ruptured plaque and clot, beside a list of vulnerable plaque features.
This slide’s list exists only in the picture; the deck has no text version of it. The six features of the vulnerable plaque: large lipid core, thin fibrous cap, rich in macrophages, increased MMPs (matrix metalloproteinases), poor in smooth muscle cells, low-grade stenosis. Note the last one: the plaque that ruptures need not be the one narrowing the artery most. Lecture 6 · Slide 24
Two cross-sections of arteries: a stable plaque with a thick fibrous cap and a vulnerable plaque with a thin cap and a clot.
A frame from the slide’s animation. Stable: thick fibrous cap, small lipid core, plenty of smooth muscle cells. Vulnerable: thin fibrous cap, large lipid core, plenty of macrophages, and a thrombus in the lumen. Smooth muscle cells build the cap; macrophages digest it. Lecture 6 · Slide 25
Lecture 7 covers atherosclerosis again, from the vessel wall’s side (section 7.7). The Lecture 7 presenter said that where the two lectures disagree the textbook prevails, and that there would be no trick questions comparing them.

6.6 · Objective g — The pathophysiology of cardiac ischemia

Ischemia starts when oxygen supply is insufficient for the demand of the cardiac cells. With less oxygen, less ATP (adenosine triphosphate) is formed (slide 30). Every cause falls on one side of the balance:

Supply falls: coronary perfusion impaired byDemand rises: workload increased by
Large atherosclerotic plaques · acute platelet aggregation, then thrombosis · vasospasm · abnormal microcirculation · poor perfusion pressures Heart rate · preload · afterload · contractility

Reduced oxygen supply to cardiac cells. The immediate metabolic consequence is that the formation of adenosine triphosphate falls.

  • When plaque builds over years, the heart develops collateral circulation to keep the muscle perfused (slide 31) — one reason a slow occlusion can be tolerated and a sudden one cannot.
  • Slowly progressive plaque formation. Collateral circulation develops over the years the plaque is growing, so the heart tolerates more narrowing; abrupt occlusion in a previously healthy vessel can do more damage than a severe chronic stenosis.
  • Myocardial oxygen consumption and myocardial blood flow correspond nearly linearly; metabolic signals are the principal determinants of oxygen delivery to the myocardium.
Heart with a circled region of damaged muscle beside three coronary artery sections: normal, atherosclerosis, and atherosclerosis with blood clot.
The progression in one image: a normal coronary artery, a narrowed atherosclerotic one, and one where a clot has formed on the plaque. The circled area on the heart is the muscle downstream that loses its supply. Lecture 6 · Slide 32

6.7 · Objective h — Coronary syndromes

Coronary syndromes are classified by the severity and onset of cardiac symptoms (slide 33):

Chronic syndromesAcute syndromes
Stable angina · ischemic cardiomyopathyUnstable angina · myocardial infarction

The dividing line is mechanism: the chronic syndromes come from a fixed narrowing that fails only when demand rises; the acute ones come from plaque rupture with acute thrombosis (section 6.9).

6.8 · Objective i — Angina pectoris

Angina is intermittent cardiac ischemia that is insufficient to kill cardiac cells. It occurs under conditions that increase the heart’s oxygen demand, and may cause insufficient pumping, leading to pulmonary congestion (slide 34).

TypeMechanismTrigger
Stable (typical) — the most commonStenotic atherosclerotic vessels reduce flow to a critical levelIncreased cardiac workload: perfusion is adequate at rest and inadequate under load
Prinzmetal (variant)Vasospasm is the probable mechanism; its cause is unknownUnpredictable; typically happens at rest rather than with exertion (emotional stress, cold, cocaine or hyperventilation can still trigger it), even though plaques are present
Unstable (crescendo)May progress to acute ischemiaClassed with the acute coronary syndromes for that reason

6.9 · Objective j — Acute coronary syndrome

Acute coronary syndrome includes both unstable angina and myocardial infarction, because they are hard to distinguish clinically. In both, pain lasts longer than typical angina, and plaque rupture with acute thrombosis is thought to occur (slide 37).

Myocardial infarction results from prolonged or total disruption of blood flow, causing cell death by necrosis or apoptosis. The initiating feature (slide 38):

  1. Thrombosis on top of an ulcerated or cracked atherosclerotic plaque
  2. Platelets adhere to the ruptured plaque, forming a platelet plug
  3. The clotting cascade is activated
  4. A growing thrombus occludes the vessel

What the occlusion does depends on collateral circulation, workload, and length of time. A typical infarct has several zones of cells in various stages of necrosis. Complete occlusion follows a pattern (slide 39):

Time after complete occlusionWhat happens
ImmediatelyATP is depleted
A few minutesThe muscle can no longer contract
After 30 minutesIrreversible cell necrosis

Where infarcts happen (slide 40). Nearly all are in the left ventricular walls:

Artery occludedShare of infarcts
Left anterior descending40–50%
Right coronary30–40%
Left circumflex15–20%

Location of myocardial infarcts. Nearly all myocardial infarcts are in the left ventricular walls, and the left anterior descending is the artery most often responsible.

How the infarcted area changes (slide 40):

TimeGross change
First several hoursHard to see with the naked eye (the slide puts the first visible change at about 6 hours)
18–24 hoursArea becomes paler
ThenYellowish and soft, with a border of red vascular connective tissue
1–2 weeksNecrotic tissue is taken away
By 6 weeksTough fibrous scar

Evolution of an infarct. The area is pale within a day, then yellowish and soft with a red border, necrotic tissue is removed by one to two weeks, and a tough fibrous scar forms by six. The scar does not contract.

6.10 · Objective k — Valvular stenosis, regurgitation and prolapse

Valves are damaged by inflammation with scarring (mitral or aortic), calcification (mitral or aortic), or congenital defects (any valve). The altered hemodynamics raise cardiac workload, and heart failure may result (slide 42).

StenosisRegurgitation (insufficiency)
DefinitionFailure of the valve to open completelyInability of the valve to close completely
Extra workPressure work: blood forced through a smaller opening; a pressure gradient forms across the valveVolume work: blood flows back across the valve and must be pumped again
Threshold / tempoHemodynamics affected at 50% closure; progresses slowly, so the heart compensates by myocardial cell hypertrophyAcute regurgitation comes from infection or papillary muscle rupture
Important causesPost-inflammatory scarring from rheumatic fever; aging valvular calcificationImportant causes include rheumatic heart disease and infective endocarditis, as well as degenerative valve changes and aortic root dilation

Hemodynamic threshold of stenosis. Stenosis begins to affect hemodynamics at about fifty percent closure, a lower threshold than the seventy-five percent that compromises coronary flow.

Slowly progressive stenosis. The heart compensates well because it hypertrophies its myocardial cells as the gradient develops, so such valves can be severely narrowed before anything is noticed.

LesionMechanismConsequences
Mitral stenosis (slides 45–46)Abnormal left atrial to left ventricular gradient during diastole: atrial pressure stays higher than ventricular pressure, and the gradient grows as the stenosis worsensLeft atrial congestion, raised left atrial pressure, raised pulmonary pressures, decreased left ventricular stroke volume. Atrial enlargement and hypertrophy → pulmonary hypertension → right-sided hypertrophy and failure. With progression: atrial fibrillation (from increased atrial volume), atrial enlargement, atrial clots
Mitral regurgitation (slide 48)Backflow from ventricle to atrium during systole; a high afterload increases the regurgitationRaised left atrial volume and pressure; the left ventricle pumps a greater volume to keep an effective stroke volume, so both atrium and ventricle dilate and hypertrophy; if severe, left-sided heart failure
Mitral valve prolapse (slide 49)Ballooning of the mitral valve into the left atrium during systoleUsually no symptoms; in a few cases enough to cause some mitral regurgitation
Aortic stenosis (slides 50–51)Most commonly age-related calcification, common with a bicuspid aortic valve; rheumatic disease is an uncommon cause, and it usually shows up years after the original rheumatic fever. Obstruction to outflow during systole creates a left ventricular to aortic gradientThe ventricle generates high systolic pressures and slowly hypertrophies; hypertrophy plus high pressure predispose to ischemia and angina; may lead to left heart failure
Aortic regurgitation (slide 53)Incompetent valve leaks from aorta back into the left ventricle during diastole; causes similar to mitral regurgitation, with aortic root dilation (from aging or connective tissue disease) a common oneLeft ventricle hypertrophies and dilates; the aortic diastolic pressure falls because blood leaks back into the ventricle; high workload can lead to left-sided heart failure

Atrial fibrillation in mitral stenosis. The atrium enlarges as its volume rises, and the enlarged fibrillating atrium then predisposes to clot within it.

Mitral stenosis and stroke volume. Left ventricular stroke volume decreases; the ventricle is not diseased, it is simply not being filled, so the problem is upstream of it.

Afterload in mitral regurgitation. High afterload increases the amount of blood regurgitated: the ventricle takes the path of least resistance, so the harder it is to eject forwards, the more goes backwards.

Aortic stenosis. It predisposes to ischemia and angina because hypertrophy and high ventricular pressures raise demand beyond what supply can meet; angina can arise with entirely normal coronary arteries.

Timing is the whole trick. Mitral stenosis and aortic regurgitation are problems in diastole; mitral regurgitation, prolapse and aortic stenosis are problems in systole. Ask which chamber is filling or emptying across the bad valve, and the consequence follows.
Slide 50 prints aortic stenosis as clinically apparent in those “over 79 years of age”. That is the figure as the slide gives it.
Gross specimen of a stenotic mitral valve seen from above, with an arrow pointing to nodular deposits on the leaflets.
A stenotic mitral valve viewed from the atrium: thickened, fused leaflets leave a narrow opening, and the arrow marks the nodular deposits along the edge. This is the fixed orifice that sets up the diastolic gradient. Lecture 6 · Slide 47
Gross specimen of an aortic valve with three cusps filled with heaped-up nodular calcium.
Calcific aortic stenosis: the three cusps are stiffened by heaped-up nodular deposits, so they cannot open fully in systole. Lecture 6 · Slide 52

6.11 · Objective l — Infective cardiopathies

ConditionMechanism
Rheumatic heart disease (slides 54–55)An uncommon but serious consequence of rheumatic fever, the acute inflammatory disease that follows infection with group A beta-hemolytic streptococcus. The damage is an immune attack caused by cross-reactivity, not the organism itself, with a genetic predisposition seen in certain HLA (human leukocyte antigen) types. The inflammation involves all layers of the heart (carditis). In the endocardium: valvular swelling, erosions, platelet aggregation and fibrin on the leaflets, and with progression scarring and shortening of the valve structures.
Infective endocarditis (slide 56)Invasion and colonization of endocardial structures by pathogens, causing inflammation. Invasion of the bloodstream is a prerequisite. Vegetations form — microorganisms enmeshed in fibrin — which grow large, interfere with valve function and predispose to emboli. Most common organisms: Streptococcus strains and Staphylococcus aureus.
Subacute infective endocarditis (slide 57)Insidious onset in people with a preexisting valve pathology. The organisms are less virulent (typically Streptococcus) and are not virulent enough to attack a healthy endocardium; the damaged valve is what lets them in. The slide also lists S. aureus and Candida; S. aureus belongs with the acute form (see the note below).
Myocarditis (slide 59)Etiologies include microbes (most often viruses, classically Coxsackievirus), immune-related disease and physical agents. The slide calls Coxsackievirus the most common cause in North America, but biopsy series now find other viruses about as often. Mechanism in section 6.14.
Acute pericarditis (slide 70)Most cases are idiopathic, and most of those are viral; the inflammation damages the pericardium. Section 6.14.

Vegetation. Microorganisms enmeshed in fibrin deposits; as they enlarge they interfere with valve function and predispose to embolism.

Slide 57 is not accurate here. It lists Staphylococcus aureus among the less virulent organisms of subacute endocarditis. S. aureus is highly virulent: it is the classic cause of acute endocarditis and can attack a normal valve (Robbins, the course text). Subacute endocarditis is typically streptococcal, on a damaged valve. The general rule holds: the less virulent the organism, the more it depends on an already-damaged valve.

6.12 · Objective m — Blood pressure regulation

No slide in the Cardiac deck teaches this objective. Lecture 7 does, on slides 19–21: blood pressure is set by cardiac output and vascular resistance, resistance is regulated at the arterioles, and a fall in pressure triggers the renin–angiotensin–aldosterone response. The full treatment is in section 7.5.

Where pressure appears in this deck, it is as load on the heart: afterload is one of the four determinants of oxygen demand (slide 31); a high afterload increases mitral regurgitation (slide 48); in aortic regurgitation the aortic diastolic pressure falls (slide 53); and poor perfusion pressure is one cause of ischemia (slide 30).

6.13 · Objective n — The cardiac conduction system

No slide in the deck covers the conduction system. The deck mentions rhythm in only two places:

  • Ischemia can lead to abnormal cardiac rhythms as well as abnormal heart function (slide 4).
  • Mitral stenosis leads, with progression, to atrial fibrillation due to the increased atrial volume (slide 46).

Nothing further is added here, so that nothing on this page goes beyond the deck. If the objective was covered aloud, those notes are the source.

6.14 · Objective o — Structural cardiac pathologies

Myocarditis (slides 59–60)

Characterized by inflammation, leukocyte infiltration and necrosis of the myocardium. The picture: left ventricular dysfunction, sometimes dilation of the chambers (the slide says all four; acute disease often has a normal-sized or only mildly dilated heart), patchy or diffuse necrotic lesions, inflamed and edematous muscle with leukocyte infiltrates, and endocardial structures that are usually normal.

Cardiomyopathy (slides 61–65)

Some have known causes. Those of unknown cause are grouped by their major pathophysiological feature:

TypeWhat the muscle doesWhy the heart fails
Dilated (also called congested)Dilation of one or both ventricles Cardiac failure with dilation. Factors: alcohol, genetics, pregnancy, post-viral
HypertrophicA thickened, hyperkinetic ventricular muscle mass Symptoms from ventricular outflow obstruction and impaired diastolic filling
RestrictiveA stiff, fibrotic, rigid, noncompliant ventricle; most related to a specific condition, for example amyloidosisRestricted diastolic filling → low stroke volume → heart failure

Dilated cardiomyopathy. Associated factors are alcohol, genetics, pregnancy and a post-viral state.

Two of the three fail in filling (hypertrophic, restrictive); one fails in emptying (dilated). The Frank–Starling slide explains why dilation helps only so far.

Pericardial disease (slides 66–72)

Rarely primary; usually secondary to another cause. Whatever the cause, fluid accumulates in the pericardial sac (the sac around the heart), and when the cause is inflammatory the pericardial structures can become painfully inflamed.

Pericardial effusion typeWhat it is and why
SerousA transudate, secondary to heart failure or hypoproteinemia
SerosanguinousSerous fluid plus blood, after blunt chest trauma, heart surgery or cardiopulmonary resuscitation
ChylousLymph, from obstruction to lymph drainage
Blood (hemopericardium)Penetrating cardiac trauma

An effusion is simply a collection of fluid; it is often non-inflammatory, watery fluid, but it can also be an inflammatory exudate when infection or inflammation is the cause. Cardiac tamponade is what happens when pericardial fluid, especially if it collects quickly, compresses the heart chambers from outside so that filling is impaired; it is life-threatening (slide 69).

PericarditisMechanism
AcuteMostly idiopathic, most of those viral; the inflammation damages the pericardium
Chronic (healed)Healing of an acute form leaves chronic dysfunction; two principal types below
Adhesive mediastinopericarditisFollows suppurative or caseous pericarditis, or surgery. The sac is destroyed and the heart adheres to the surrounding mediastinal structures, so every beat pulls against them and workload rises
Constrictive pericarditisMany causes unknown; can share the adhesive form’s causes. The sac becomes dense, nonelastic, fibrous and scarred, and encases the heart like a stiff cage, impairing diastolic filling

Cardiac tamponade. Tamponade is external compression of the chambers by pericardial fluid, which prevents filling, so the muscle and valves may be entirely normal while output collapses.

Three ways to stop a heart filling, three different places: fluid around it (tamponade), a scarred cage around it (constrictive pericarditis), or a stiff muscle within it (restrictive cardiomyopathy). The effect on filling is the same; the anatomy differs.
Source: 6. Cardiac Pathophysiology for posting.pptx (deck prepared by Matthew Ward, DMSc, MBA, PA-C). No lecture recording. Figures are reproduced from the lecture slides and each is cited to its slide.

7 · Vascular Pathophysiology

Lecture 7 · 15 September 2026 · deck title slide: “Presented by Stacie Gopal, DMS, PA-C”, “Adapted from Lauren Reynolds, PA-C”. The calendar row names Professor Reynolds; the deck’s own wording is used here.

Instructional Objectives

  1. Review the anatomy of the vascular system
  2. Review the functions of the components of the vascular system
  3. Describe the molecular mechanisms of common vascular pathologies
Objective (c) on the slide reads “molecular mechanisms of vascular pathologies”, without common. The syllabus wording is used above.

7.0 · What the recording adds

The 51-minute recording was read in two independent transcriptions and cross-examined. Both agree on everything below. Timestamps are minutes into the recording.

★ Professor emphasized — stated in the lecture
SaidWhat it means for the exam
“Do know that a consequence of atherosclerosis is peripheral arterial disease… an individual might experience claudication… because there’s a lack of oxygenated blood supply to that musculature under increased demand.” [33:43]The one explicit “do know” in the lecture. The mechanism: stenosis → ischemia that shows only when demand rises, exactly like stable angina in section 6.8.
“Notice the size of the arteries, because much of what we’re going to be discussing today involves the large versus medium versus small.” [1:51]; “the take home point is that it affects different vessels based on their size and physiologic purpose.” [43:21]The organizing principle of the whole lecture: large elastic arteries → aneurysm; medium muscular arteries → atherosclerosis; small arteries and arterioles → hypertension (section 7.4).
“Principal mechanisms of vascular disease, it’s kind of easy, it’s two things. It’s either narrowing of the vessel… or weakening of the vessel, which would be dilation and rupture.” [22:08]Sort every disease in this lecture into one of the two bins.
“An aneurysm means a weakening of the wall, it does not mean a rupture of the wall.” [38:55]Answering a student’s question: not all aneurysms rupture; the risk depends on size (section 7.8).
“You are held responsible for the textbook information too.” [21:59]; “If there’s any discrepancy… the textbook is going to be the rule to prevail… but I won’t put any trick questions on the test trying to compare these two, I promise.” [33:27]Said of the overlap with the Cardiac lecture on atherosclerosis. She pointed at the textbook’s Figure 11.3 (the neointimal response) and its Key Concepts box (section 7.3).
★ Said to go light on
  • Vasculitis: “more than 20 forms… I just threw out a couple of examples there, but again this is not something we can dive into in tremendous detail today.” [43:15, 44:38]
  • Mycotic aneurysm: “These are very rare, but it’s there for the sake of completeness.” [42:08]
  • Atherosclerosis was presented as a quick review, “because I know it was covered yesterday” [30:11]. Section 6.5 is the full version.
Two transcription slips, both corrected by the slide. Both transcriptions write the capillary’s contractile cells as “parasites”; the slide 11 figure labels them pericytes. And “Mockingbird medial sclerosis” is Mönckeberg medial sclerosis (slide 22).

7.1 · Objective a — Anatomy of the vascular system

The vascular system is a closed network of blood and lymph vessels. On the slide 3 overview, the numbered structures are 1 aorta, 2 pulmonary artery, 3 right heart, 4 left heart, 6 abdominal aorta (there is no 5). Slides 4 and 7 show the named arteries and veins, superficial and deep veins, and the hepatic portal system, where veins from the stomach and intestines enter the liver so that nutrients are processed and drugs metabolized on first pass.

From heart and back: the five components (slides 8–9)

Diagram of the circulation from aorta to large vein, with a cross-section of each vessel type and labels for high pressure, blood pressure control, gas and nutrient exchange and low pressure.
Follow the loop clockwise from the heart: elastic artery (aorta; elastin fibers between smooth muscle), muscular artery (densely packed concentric smooth muscle), arteriole (labeled blood pressure control), capillary (endothelium and pericytes only; gas and nutrient exchange), then post-capillary venule, medium vein, large vein. Left side low pressure, right side high pressure: the walls thin as the pressure falls. Lecture 7 · Slide 9

The three layers (slide 10)

LayerStructure
IntimaA single layer of endothelial cells on a basement membrane, with a thin underlying layer of extracellular matrix
MediaIn elastic arteries such as the aorta, lamellar units of elastin fibers and smooth muscle cells arranged like tree rings, which expand during systole and recoil during diastole
AdventitiaLoose connective tissue for support; can carry nerve fibers; in large vessels it holds their own small arterioles (vasa vasorum) that perfuse the adventitia and part of the media

All three layers are present in arteries and veins, though more clearly demarcated in the thicker arterial wall. The amount of smooth muscle and matrix in the media varies with the hemodynamic demand of the vessel’s location. Capillaries are the exception: they have no media.

Capillaries (slide 11)

A capillary is equal to or slightly smaller than the diameter of a red blood cell — in the lecture, roughly 5–10 micrometers against a red cell of 7–8. The lumen is lined with endothelium and has no media. Capillaries have a large cross-sectional area and a low flow rate; thin walls plus slow flow make exchange easy. Tissues with high metabolic rates, myocardium and brain, have the highest capillary density.

Three capillary types drawn in section: continuous with pores, fenestrated with fenestrations, and sinusoidal with gaps and a discontinuous basement membrane.
Continuous (least permeable; the blood–brain barrier), fenestrated (windows; kidney glomeruli, small intestine), sinusoidal (gaps, large fenestrations, discontinuous basement membrane; liver, bone marrow, spleen, endocrine glands). Note the pericyte wrapped around each one. Lecture 7 · Slide 11

Capillary diameter. Equal to or even slightly smaller than a red blood cell, so red cells must deform to pass, bringing their membranes into close contact with the endothelium.

7.2 · Objective b — Functions of the components of the vascular system

Function of the vascular system (slide 5)
NutrientsTransported to tissues
Waste productsTransported away from tissues
HormonesTransported from one part of the body to another
HomeostasisBalance in all tissue fluids, for the function of cells

Two circulatory loops (slide 6). Pulmonary: deoxygenated blood from the right heart to the lungs. Systemic: oxygenated blood from the left heart to the tissues, returning deoxygenated blood to the right heart. The naming rule she stopped on: an artery carries blood away from the heart and a vein toward it, which is why the pulmonary artery carries deoxygenated blood and the pulmonary vein oxygenated.

Component (slide 8)Function
1 · ArteriesHigh pressure, strong walls, high-velocity flow
2 · ArteriolesControl conduits for the release of blood into the capillaries — the principal points of resistance to flow (“small but mighty”)
3 · CapillariesExchange of fluid, nutrients, electrolytes, hormones and wastes between blood and tissue
4 · VenulesCollect blood from capillaries and coalesce into larger veins
5 · VeinsReturn blood to the heart; major reservoir of extra blood; low pressure, thin walls

Arteries. High pressure, strong walls, high flow velocity; veins, by contrast, are low pressure with thin walls and serve as the major reservoir of extra blood.

Veins hold about 66% of the total blood volume (slide 35), so maintaining that volume is a large part of maintaining blood pressure.

7.3 · Objective c — The healthy wall and its response to injury

Cell (slide 12)What it does in health
Endothelial cells — specialized simple squamous epithelium lining the lumen Vessel homeostasis; a nonthrombogenic surface that keeps blood fluid; modulates medial smooth muscle tone and so vascular resistance; metabolizes hormones such as angiotensin; regulates inflammation; affects the growth of other cells, particularly smooth muscle
Smooth muscle cells — the predominant cell of the mediaNormal vascular repair, and a large part in atherosclerosis: they proliferate when stimulated, synthesize collagen, elastin, proteoglycans, growth factors and cytokines, and are responsible for vasoconstriction and vasodilation

Nonthrombogenic endothelial surface. It keeps blood in a fluid state; this is an active property, and endothelial injury lets platelets adhere and a thrombus begin.

Intimal thickening (slides 13–15)

Vascular injury with endothelial dysfunction or loss stimulates smooth muscle cell recruitment and proliferation into the intima:

  • Endothelial cells migrate in from uninjured areas or come from precursor cells in the blood — and nitric oxide production falls.
  • Smooth muscle cells (or circulating precursors) migrate into the intima, proliferate and synthesize extracellular matrix — the primary pathology of neointimal hyperplasia.
  • Platelets activate (a thrombus forms) and leukocytes are recruited (the inflammatory cascade begins).
  • Neointimal response. Platelet activation and leukocyte recruitment accompany it: a thrombus forms and the inflammatory cascade begins at the injury site.

The result is a thickened intima that narrows the lumen and compromises flow. This neointimal response happens with any form of vascular damage, regardless of cause, and involves wall remodeling and loss of lumen patency.

Why falling nitric oxide matters twice (her question to the room, [18:48]): nitric oxide is a vasodilator. So the injured vessel is narrowed by the thickened intima and constricted by the loss of dilation — a “twofold problem”.

Endothelial repair and nitric oxide. Nitric oxide production decreases; because nitric oxide is a vasodilator and an inhibitor of platelet adhesion, losing it shifts the vessel toward constriction and thrombosis.

Diagram of a vessel wall showing smooth muscle cells crossing the internal elastic lamina into the intima, dividing, and laying down extracellular matrix.
The textbook’s Figure 11.3, in three numbered steps: (1) recruitment of smooth muscle cells or their precursors into the intima, across the internal elastic lamina; (2) smooth muscle cell mitosis; (3) elaboration of extracellular matrix. The intima widens; the lumen narrows. Lecture 7 · Slide 14

Key Concepts, response of vascular wall cells to injury (slide 15, an image of the textbook’s box; transcribed here because the deck has no text copy):

  • All vessels are lined by endothelium; endothelial cells in specific vascular beds have special features for tissue-specific functions (for example, fenestrated endothelium in renal glomeruli).
  • Endothelial function is tightly regulated. Stimuli can shift the phenotype: procoagulant versus anticoagulant, proinflammatory versus anti-inflammatory, adhesive versus nonadhesive.
  • Injury of almost any type to the wall produces a stereotyped healing response: smooth muscle proliferation, matrix deposition, and intimal expansion.
  • Smooth muscle recruitment is signaled by endothelial cells, platelets and macrophages, and by mediators from the coagulation and complement cascades.
  • Excessive intimal thickening can cause luminal stenosis and vascular obstruction.

7.4 · Objective c — Two mechanisms, three sizes of artery

The principal mechanisms of vascular disease (slide 16): narrowing — stenosis or obstruction of the lumen, either progressive (atherosclerosis) or precipitous (thrombosis, embolism) — and weakening, which leads to dilation or rupture. Each vessel type has its own structure for its own physiologic needs, so each size of artery tends to be tied to one typical pattern of disease (slide 17; the patterns overlap, for example atherosclerosis also affects the aorta):

Artery type (slide 18)ExamplesTypical disease and why
Large (elastic) — aorta about 2–3.5 cmAorta and its major branches, such as the iliac arteriesAneurysm: weakening from loss of elastic tissue
Medium (muscular) — coronary arteries 3–4 mmSmaller aortic branches: coronary and renal arteriesAtherosclerosis: narrowing by intimal thickening, in arteries built with elastic and muscular components to withstand high pulsatile force and recoil
Small arteries (2 mm or less) and arterioles (20–100 micrometers) Within tissues and organsHypertension: mechanical stress, endothelial dysfunction, less elasticity and weakening, while the lumen stiffens and narrows

Where references differ. The slide ties atherosclerosis to medium-sized muscular arteries, and that is what is tested; current references also count the aorta and iliac arteries among its principal sites.

Four principal mechanisms of vascular disease. Weakening, narrowing, dilation and rupture. Narrowing itself can be progressive, as in atherosclerosis, or precipitous, as in thrombosis or embolism.

Narrowing of a vessel lumen. Narrowing can arise progressively or precipitously. Atherosclerosis narrows progressively; thrombosis or embolism narrows precipitously. A gradual stenosis allows collateral supply to develop while a sudden one does not.

A wording slip on slide 18. It says atherosclerosis narrows the vessel “through intimal neoplasia”. The deck’s own slide 13, and the textbook figure it cites, describe the process as neointimal hyperplasia; a neoplasia would be a tumor. Read it as hyperplasia.

7.5 · Objective c — Blood pressure regulation and hypertension

Blood pressure is determined by vascular resistance and cardiac output (slide 19):

  • Vascular resistance is regulated at the arterioles, by neural and hormonal input, as a balance of vasoconstrictors (such as angiotensin) and vasodilators (such as nitric oxide).
  • Cardiac output is heart rate times stroke volume, and stroke volume depends on blood volume, which is regulated by sodium excretion or resorption. Water follows sodium: more sodium in the blood pulls in water, raising volume and so pressure — one reason chronic high sodium intake contributes to hypertension.
Diagram: blood pressure equals cardiac output times peripheral resistance, with the factors acting on each.
Blood pressure = cardiac output × peripheral resistance. Cardiac output is fed by blood volume (sodium, mineralocorticoids, atrial natriuretic peptide) and cardiac factors (heart rate, contractility). Resistance is fed by humoral constrictors (angiotensin II, catecholamines, thromboxane, leukotrienes, endothelin) and dilators (prostaglandins, kinins, nitric oxide), neural factors (alpha-adrenergic constrict, beta-adrenergic dilate), and local factors (autoregulation, pH, hypoxia). Lecture 7 · Slide 21

When pressure falls: the renin–angiotensin–aldosterone response

  1. The kidneys secrete renin in response to decreased pressure in the afferent arterioles.
  2. Renin cleaves angiotensinogen to angiotensin I.
  3. Endothelial catabolism produces angiotensin II, a vasoconstrictor.
  4. Angiotensin II raises pressure by increasing smooth muscle tone and adrenal aldosterone secretion, which increases renal sodium resorption.

When pressure is high: hypertension (slide 20)

A common disorder and a risk factor for atherosclerosis, congestive heart failure, renal failure, cerebral hemorrhage and aortic dissection.

Essential hypertensionSecondary hypertension
Share90–95%, idiopathicMuch less common
MechanismGenetic plus environmental factors; suspected small changes in renal sodium homeostasis and/or vessel wall tone and structure. Insufficient renal sodium excretion at normal arterial pressure → more fluid volume → more cardiac output → more vasoconstriction → raised pressureRenovascular: renal artery stenosis lowers glomerular flow and afferent arteriolar pressure, which induces renin secretion and raises volume and tone. Primary hyperaldosteronism is a common cause (in the lecture, for example from an adrenal adenoma)

7.6 · Objective c — Arteriosclerosis

Literally “hardening of the arteries”: the generic term for arterial wall thickening and loss of elasticity. Four patterns (slide 22):

PatternMechanism and features
Arteriolosclerosis of small arteries and arteriolesCan cause downstream ischemic injury. Two subtypes, both related to hypertension: hyaline and hyperplastic
Fibromuscular intimal hyperplasiaIn muscular arteries larger than arterioles, driven by inflammation or mechanical injury; a healing response. Vessels can become very stenotic — for example in-stent restenosis — and it is a major long-term limitation of solid-organ transplants
Mönckeberg medial sclerosisCalcification of the media of muscular arteries; usually not clinically significant (in the lecture, adults over 50)
AtherosclerosisGreek for “gruel” and “hardening”; the most clinically relevant form (section 7.7)
Two micrographs: A, an arteriole with a thick pink glassy wall and narrow lumen; B, an arteriole with concentric onion-skin layers.
A, hyaline: the wall is thickened by protein deposition, glassy pink, and the lumen is markedly narrowed. B, hyperplastic: concentric layers of smooth muscle cells, the “onion skinning” she named, obliterating the lumen. Lecture 7 · Slide 23

7.7 · Objective c — Atherosclerosis, from the vessel wall

The major pathogenesis of coronary, cerebral and peripheral vascular disease, and the cause of more morbidity and mortality in the Western world than any other disorder — slide 24 says about half of all deaths, an older figure; cardiovascular disease accounts for roughly a third of deaths in the United States today. Risk comes from acquired, inherited, sex- and age-related factors:

Risk factor (slide 24)What the lecture adds
Hyperlipidemia—
Lipoprotein(a)An altered form of low-density lipoprotein; risk independent of total cholesterol
Smoking · hypertension · diabetes mellitus—
Metabolic syndromeCentral obesity, insulin resistance, hypertension, dyslipidemia; induces a hypercoagulable and proinflammatory state
Inflammation (C-reactive protein)Now included in cardiovascular risk stratification
GeneticsFamily history is a strong risk factor, classically taught (on the slide) as the most important one
Increasing ageProgressive; manifests in the 40s to 60s and rises by decade
Men and postmenopausal womenLikely a protective effect of estrogen

The sequence (slide 25). A chronic inflammatory and healing response of the arterial wall to endothelial injury:

  1. Healthy vessel is injured (think risk factors)
  2. Low-density lipoprotein accumulates in the wall
  3. Monocytes adhere to the endothelium
  4. Platelets adhere
  5. Smooth muscle cells are recruited, by factors released from activated platelets and macrophages
  6. Smooth muscle proliferates, extracellular matrix is produced, T cells are recruited
  7. Lipid accumulates
  8. Matrix and necrotic debris calcify

End of the atherosclerotic sequence. The final two steps are lipid accumulation, then calcification, which involves matrix and necrotic debris.

★ Professor emphasized

Peripheral arterial disease is the consequence she told the class to know: the arteries become stenotic, which causes ischemia; with increased metabolic demand (walking) the patient has claudication, from lack of oxygenated blood to the working muscle (slide 25, [33:43]).

Diagram of an atheroma in the intima: a fibrous cap over a yellow necrotic center, above the media.
The atheroma: an intimal lesion that projects into the lumen, with a soft lipid core under a fibrous cap. The labels: fibrous cap (smooth muscle cells, macrophages, foam cells, lymphocytes, collagen, elastin, proteoglycans, neovascularization); necrotic center (cell debris, cholesterol crystals, foam cells, calcium). Stable plaques cause ischemia; unstable ones rupture, thrombose and embolize. Lecture 7 · Slide 26

7.8 · Objective c — Aneurysms and dissection

An aneurysm is a localized abnormal dilation of a vessel, congenital or acquired, classified by shape. A dissection is blood entering a defect in the arterial wall and tunneling through the medial or medial-adventitial planes (slide 27).

Five vessel outlines: normal, saccular true aneurysm, fusiform true aneurysm, false aneurysm with hematoma, and dissection with an intimal tear.
A normal; B true aneurysm, saccular (a focal outward bulge; the berry shape); C true aneurysm, fusiform (circumferential dilation); D false aneurysm — the wall has ruptured and the hematoma is held in only by extravascular connective tissue; E dissection — a tear in the intima lets blood split the media. Lecture 7 · Slide 27

Dissection. Blood enters a wall defect and tunnels through medial (or medial-adventitial) planes, so the wall is split into layers rather than merely dilated.

Pathogenesis (slide 28). Arterial walls constantly remodel; anything that compromises the connective tissue of the wall can produce aneurysm or dissection:

Route to a weak wallExamples
Poor connective tissue qualityDefective collagen synthesis; abnormal transforming growth factor signaling (Marfan syndrome)
Imbalance of collagen degradation and synthesisAltered by inflammation and proteases; a genetic predisposition in the setting of inflammatory lesions
Loss of smooth muscle cells or inappropriate matrix synthesisIschemia, hypertension, tertiary syphilis

Wall basis of aneurysm and dissection. Compromised wall connective tissue, in either structure or function, underlies both lesions, because arterial walls are constantly remodelling; histopathological change follows.

Predisposing conditions for aortic aneurysm: atherosclerosis, hypertension, smoking.

Aortic lesion (slide 29)Mechanism and association
Abdominal aortic aneurysmAtherosclerotic aneurysms occur most commonly in the abdominal aorta and common iliac arteries. Rupture risk rises with size: in the lecture, under 4 cm they typically do not rupture and over 5.5 cm the risk is very high
Thoracic aortic aneurysmCommonly associated with hypertension; also Marfan syndrome and inflammation (and, in the lecture, a bicuspid aortic valve, which raises local hemodynamic stress)
Aortic dissectionThe laminar planes of the media split to form a blood-filled channel in the wall. Hypertension is the major risk factor. In the lecture: two groups, ages 40–60 with hypertension, or younger patients with connective tissue disorders such as Marfan; also a sudden pressure spike (cocaine) or iatrogenic injury during catheterization
Cerebral aneurysm (slide 30)Features
Saccular (berry)Thin-walled protrusions with very thin or absent media and absent or fragmented internal elastic lamina; typically acquired. Multifactorial: hemodynamic stress, turbulent flow causing structural fatigue, hypertension, smoking, connective tissue disease, possibly inflammation. Lack of elastic lamina is the main feature.
FusiformDilation of the entire circumference; atherosclerosis may be a factor
MycoticUsually from infected emboli in infective endocarditis (rare; see section 6.11)

7.9 · Objective c — Fibromuscular dysplasia, vasculitis, Raynaud phenomenon, arteriovenous fistula

Fibromuscular dysplasia (slide 31)

A focal irregular thickening of medium and large muscular arteries, exact cause unknown. Segments of wall are thickened by hyperplasia and fibrosis of the media and intima, causing luminal stenosis. Example: the renal arteries (in the lecture also carotid and vertebral; in the renal arteries it can cause renovascular hypertension). The angiographic sign is a “string of beads”, and it may lead to aneurysmal dilation that can rupture.

Six panels of computed tomography and catheter angiography images of renal arteries with beaded and focal narrowing.
Renal arteries on computed tomography (left) and catheter angiography (right). Panels C and D show the classic string of beads: alternating narrowing and dilation along the vessel. The slide’s note credits the American Heart Association source. Lecture 7 · Slide 31

Vasculitis (slide 32)

Vessel wall inflammation, with manifestations set by the vessel affected; any organ or vessel, but mostly small vessels. About 20 primary forms. Two main pathogenic mechanisms: immune-mediated inflammation, and direct invasion of the wall by infectious pathogens.

Vessel sizeExamples on the slide
LargeGiant cell arteritis (in the lecture: carotid, vertebral and temporal arteries; granulomatous inflammation)
MediumPolyarteritis nodosa; Kawasaki disease (in the lecture: an acute febrile illness of children under 5)
SmallTwo subgroups: ANCA (anti-neutrophil cytoplasmic antibody)-associated necrotizing vasculitis; immune complex vasculitis, as in systemic lupus erythematosus and rheumatoid arthritis

Raynaud phenomenon (slide 33)

An exaggerated vasoconstrictive response to cold and emotional stress, mostly in the arteries and arterioles of the extremities. Vasoconstriction → tissue anoxia → return of oxygenated blood produces the color sequence white → blue → red. In the lecture: white from constriction, blue from lack of oxygen, red when flow returns, which is painful because of rapid vessel dilation and a rush of inflammatory signals.

Illustration of a hand with a white finger and a blue finger, and insets of vasospastic and relaxed blood vessels.
The white and blue phases in the fingers, with the vessel behind each: vasospastic (narrowed) against relaxed. Lecture 7 · Slide 33

Arteriovenous fistula (slide 34)

An irregular direct connection between an artery and a vein, bypassing the capillaries. Causes: developmental defects; rupture of an arterial aneurysm into an adjacent vein; penetrating injury that pierces artery and vein; inflammatory necrosis of adjacent vessels; or surgical creation for hemodialysis access, to carry high flow at a rapid rate. In the lecture: the vein then remodels until its wall can withstand arterial pressure.

7.10 · Objective c — Veins: varicosities and deep vein thrombosis

Veins have larger diameters and lumens than arteries and hold about 66% of total blood volume. Their thinner media allows greater capacitance, and venous valves prevent gravitational reverse flow. As with arteries, location and structure predict the disease (slide 35):

VeinsExamplesTypical disease
SuperficialGreat and small saphenousVaricose veins, from insufficiency of the venous valves; usually the lower extremities (flow against gravity), also pelvis and rectum (hemorrhoids)
DeepFemoral, popliteal, tibialStasis in a dilated vein → thrombosis (deep vein thrombosis)

Varicosities (slide 36). Varicose veins are dilated, tortuous veins caused by chronic high intraluminal pressure and weakened wall support. Esophageal varices are dilated submucosal distal esophageal veins from cirrhosis and portal venous hypertension. Hemorrhoids are varicose dilations of the venous plexus at the anorectal junction. In the lecture, varicose veins and hemorrhoids were both linked to pregnancy.

Illustration of a leg with varicose and spider veins, and insets comparing a normal vein and valve with a damaged valve and a varicose vein.
Top inset: a normal valve closes and blood moves one way. Bottom inset: a damaged valve lets blood fall back, and the vein below it balloons into a varicosity. Lecture 7 · Slide 36

Deep vein thrombosis (slides 37–38)

A clot in a deep vein, typically of the legs; the third most common cause of death from cardiovascular disease.

Where references differ. The slide's ranking is what is tested; most references rank venous thromboembolism as the third most common acute cardiovascular syndrome, after myocardial infarction and stroke.

Risk factor (slide 37)Examples
Reduced blood flowImmobility (in the lecture: bed rest, general anesthesia, the postoperative state, stroke, a long flight)
Increased venous pressureMechanical compression or functional impairment
Mechanical injuryTrauma, surgery, intravenous drug use, iatrogenic
Increased blood viscosityDehydration, thrombocytosis
Anatomic variations—
Increased coagulation (genetic or acquired)Cancer, sepsis, systemic lupus erythematosus, oral estrogen

Virchow triad (slide 38): (1) damage to the vessel wall, (2) abnormal blood flow, meaning turbulence or stasis (pooling), (3) hypercoagulability (blood that clots too easily). The slide names turbulence; stasis, as in deep vein thrombosis, counts as well. Triggers are multifactorial, with the three involved in varying degrees.

What happens to the clot. Over weeks, neutrophils and macrophages infiltrate the fibrin clot, and collagen gradually replaces the fibrin; that remodeling and fibrosis decrease blood flow. If the thrombus dislodges it becomes an embolus that travels through the venous system to the pulmonary artery, occluding it: a pulmonary embolus.

Illustration of a leg with a deep vein, and a sequence of panels: healthy vein with valve, pooling blood, blood clot, embolus.
The sequence from stasis to embolus: healthy vein and valve → pooling blood → blood clot (thrombosis) → a fragment breaks free as an embolus. Lecture 7 · Slide 38
Source: SV Vascular Pathophys I Fall 2026.pptx (presented by Stacie Gopal, DMS, PA-C; adapted from Lauren Reynolds, PA-C) and the lecture recording of 15 September 2026. Figures are reproduced from the lecture slides and each is cited to its slide.

8 · Immunity

Lecture 8 · 19 October 2026 · a narrated deck (one recorded clip per slide) by Matthew Ward, DMSc, MBA, PA-C (deck title slide: “Lectured Prepared by: Matthew Ward, DMSc, MBA, PA-C”).

Instructional Objectives

  1. Describe the molecular mechanisms involved in immune processes
  2. Compare and contrast the various types of immunological processes
  3. Compare and contrast acquired and innate immunity
  4. Compare and contrast natural and artificial immunity
  5. Compare and contrast the various types of blood cells and their roles in immunity
  6. Define the function and specific types of antigens
  7. Describe the antigens’ ability to promote an immune response
  8. Compare and contrast primary and secondary immune response by the body
  9. Describe B lymphocyte and its metamorphosis into plasma cells
  10. Define antibodies (immunoglobulins)
  11. Compare and contrast the morphology of the various types of antibodies
  12. Compare and contrast the functions of the various types of antibodies and the various mechanisms by which antibodies destroy antigens
  13. Describe the process known as cellular immunity
  14. Describe T-lymphocytes
  15. Compare and contrast the various subtypes and various functions of T lymphocytes
  16. Compare and contrast the various mechanisms that T lymphocytes destroy antigens
  17. Define the concept of hypersensitivity
  18. Compare and contrast the types of hypersensitivity reactions
  19. Describe the function of the complement system
  20. Define autoimmunity
  21. Compare and contrast examples of autoimmune diseases
  22. Compare and contrast primary and secondary immunodeficiency including the genetic basis
  23. Describe the effect of aging on the immune system
The deck and the syllabus list the objectives differently. The deck’s own objectives slides (2–3) number them 1–24 with no 8 or 13, and word several differently (“acquired and artificially immunity”, “age affect on the immune system”). The list above is the syllabus verbatim. Two syllabus objectives have no slide of their own: (t) define autoimmunity and (u) examples of autoimmune diseases. Section 8.12 collects everything the deck does say about them.

8.0 · What the narration adds

Every slide carries its own recorded narration (118 minutes in all, transcribed slide by slide). There was no second recording to cross-check against. The narration sets two things here: which topics get the most questions (by the minutes spent on each slide) and the stars below. Every fact in this section comes from the slides themselves.

Where the minutes wentMin
Blood cells in immunity (slides 14–21)16.2
Antibody functions, agglutination to opsonization (slides 47–59)14.4
Hypersensitivity (slides 60–65)12.2
Complement (slides 66–75)11.2
T cells and cellular immunity (slides 24–25, 30–34)10.9
Antibody classes (slides 44–46; slide 44 alone was 4.3 minutes, the longest slide)7.9
Antibody structure (slides 39–43)7.6
Immunodeficiency and aging (slides 76–77)6.7
★ Professor emphasized — said in the narration
SaidWhat it points at
“To help remember CD4 versus CD8, CD4, there’s four letters in help. So CD4 is our helper cells and cytotoxic would then be CD8.” (slide 25); “When you mentioned CD4, think helper T cells.” (slide 30) The CD4 helper / CD8 cytotoxic split, and which presenting molecule each reads (section 8.9).
“The thymus starts with a T, so think T cells, thymus.” (slide 19); “Baso B blood and mast cells are in tissue.” (slide 15)Two memory hooks for section 8.3.
“So secondary response is usually faster, larger, quicker response than primary… IgM is primary and usually the first one. And IgG commonly dominates the systemic secondary response.” (slide 36)Section 8.5 and the graph on slide 37.
“So IgG is how maternal immunity is passed to babies in the womb.” (slide 44)IgG crosses the placenta: natural passive immunity (sections 8.2 and 8.7).
“If you’re measuring immunoglobulin levels and there’s a high IgM present, what does that suggest? This is the first time that that person’s ever been exposed to that illness. Whereas if IgM is low and IgG is high, it could suggest that they’ve already been exposed prior.” (slide 46)Reading the primary/secondary pattern from the classes (section 8.5).
“It also makes sense why O is the universal donor.” (slide 49)Group O red cells carry neither A nor B antigen (section 8.8).
“Just keep in mind, neutralization does not mean necessarily the particle is being destroyed.” (slide 52)Neutralization blocks without destroying (section 8.8).
“They’re organized by the immune mechanism that is responsible rather than by how severe the reaction is… The numbers identify these mechanisms, so it’s not a scale, it’s not the severity… those are the main things you should be keeping in mind between the types.” (slide 60)Hypersensitivity types I–IV (section 8.10).
“One small signal could cause a major response… So that’s why it’s important to know the pathways.” (slide 66)The three complement pathways converging on C3 (section 8.11).
“Just remember, cell lysis is one possible outcome… just because you’re not seeing lysis does not mean complement has not been activated.” (slide 74)Complement also opsonizes and inflames (section 8.11).
Left out on purpose. The last line of slide 62 is about treating anaphylaxis; this course is mechanism, not management, so it is not taught here. The narration also names a few specific genes and associated infections that no slide shows; under the slides-only rule they are not used. Two transcription slips, corrected by the slides: the transcript of slide 44 writes “IgG” where the slide (and the lecturer’s meaning) is IgE binding mast cells and causing anaphylaxis, and on slide 60 the lecturer corrects himself from “IgG or IgE” to IgE for type I.

8.1 · Objectives a & b — The machinery and the processes of immunity

The lymphatic system (slides 4–8)

The labeled lymphatic system: tonsils, thymus gland, spleen, appendix, lymph vessels of the chest and abdomen, the thoracic duct and the right lymphatic duct, and lymph nodes of the neck, axilla, groin and behind the knee. T lymphocytes are processed in the thymus (slide 19).

Lymphatic capillary with overlapping endothelial cells, interstitial fluid entering between them, open and closed valves, anchoring fibers and the direction of flow.
The lymphatic capillary. Overlapping endothelial cells act as one-way valves: interstitial fluid enters where their edges part (valve open) and cannot leave (valve closed). Anchoring fibers tether the wall to the tissue. Lecture 8 · Slide 7

Larger lymphatic vessels have smooth muscle and internal valves. There is no central pump: skeletal muscle movement, pressure changes in the thorax during breathing and the pulsations of adjacent arteries propel lymph, and physical activity or passive movement keeps it flowing (slide 8).

Immune response, immunity and its three functions (slide 9)

The immune response is the cellular defense reactions of the body that protect against threats. Immunity is a state of protection, with three functions:

FunctionMeaning
DefenseResistance to invaders
SurveillanceOf self, for mutant or cancerous cells
HomeostasisRemoving cellular debris

Memory and specificity (slide 10)

  • Memory: a faster, stronger adaptive response on re-exposure to an antigen.
  • Adaptive specificity: B-cell and T-cell receptors recognize particular epitopes.
  • Innate receptors recognize patterns shared by groups of organisms.

Two kinds of immune response (slides 22, 25)

Humoral immunityCellular (cell-mediated) immunity
Works throughAntibodies (immunoglobulins)T cells
EffectorPlasma cells, transformed from B cells, are the actual antibody-producing cellsKiller T cells (CD8, cytotoxic) destroy virus-infected, tumor and transplanted cells; perforin release is important

Phagocytosis, step by step (slides 26–28)

  1. The microbe adheres to the phagocyte.
  2. Pseudopods engulf the particle into a phagocytic vesicle, the phagosome.
  3. The phagosome fuses with a lysosome: the phagolysosome.
  4. Acid hydrolase enzymes kill and digest the microbe, leaving a residual body.
  5. Indigestible residual material is removed by exocytosis.
A macrophage engulfing bacteria beside a numbered diagram of phagocytosis from adherence to exocytosis.
1 Microbe adheres to the phagocyte. 2 Pseudopods engulf it into a phagocytic vesicle (phagosome). 3 The vesicle fuses with a lysosome: the phagolysosome. 4 Lysosomal enzymes (acid hydrolases) kill and digest the microbe, leaving a residual body. 5 Indigestible material is removed by exocytosis. Lecture 8 · Slide 26

8.2 · Objectives c & d — Acquired and innate; natural and artificial

Category (slides 11–13)What it isNaturalArtificial
Active (acquired)Acquired by the body’s own processes after exposure to the antigenThe body comes in contact with the antigen naturallyAntigen exposure done on purpose: vaccination
Passive (acquired)Transfer of preformed antibodies from another source; immediate protection that declines as the transferred antibodies are lostMaternal IgG through the placenta, IgA in breast milkTetanus immune globulin, rabies immune globulin

Innate immunity (slide 13) is the set of defenses that act without prior sensitization to a particular antigen. It recognizes conserved microbial patterns and signs of cell injury, and includes skin and mucosal barriers, phagocytes, complement and interferons. Natural killer cells provide its cytotoxic defense and are approximately 5–15% of circulating lymphocytes. Host characteristics contribute to species-specific resistance.

Two questions sort every example. Did the person’s own body make the response (active) or receive antibodies ready-made (passive)? And did the exposure happen in the course of life (natural) or on purpose (artificial)? A vaccine is active-artificial; maternal IgG is passive-natural; immune globulin is passive-artificial.

8.3 · Objective e — The blood cells and their roles in immunity

Hematopoiesis tree from the hematopoietic stem cell through progenitors to lymphocyte, monocyte, granulocytes, erythrocyte and platelets.
Formation of blood cells. From the hematopoietic stem cell (HSC) through progenitors: the lymphoblast to the lymphocyte, the monoblast to the monocyte, the myeloblast to the eosinophil and basophil, the promyelocyte line to the neutrophil, the erythroid line to the erythrocyte, and the megakaryocyte to platelets. Lecture 8 · Slide 14

The neutrophil line (slide 14): promyelocyte → myelocyte → metamyelocyte → band form → segmented neutrophil. The band form immediately precedes the segmented neutrophil. On the slide the promyelocyte comes straight from the progenitor, and the myeloblast gives the eosinophil and the basophil. Standard texts start the neutrophil line at the myeloblast too; the exam follows the slide.

Cell (slides 15–19)Role
Neutrophil (granulocyte; “poly”, PMN (polymorphonuclear leukocyte)) Phagocytosis; the first responders, most numerous
Eosinophil (granulocyte)Allergic reactions and parasitic invasion
Basophil (granulocyte)Similar to tissue mast cells
Monocyte / macrophage (agranulocyte)Monocytes circulate in blood and enter tissues during inflammation, where tissue signals turn them into macrophages. Some resident macrophages develop before birth and renew locally. Macrophages remove material and coordinate inflammatory responses. A histiocyte is a tissue macrophage.
B lymphocyte (agranulocyte)Humoral immunity; becomes the plasma cell
T lymphocyte (agranulocyte)Cellular immunity; processed in the thymus
Natural killer cellUnlike cytotoxic T cells, does not need to recognize a specific antigen; targets tumor cells and protects against a wide variety of infectious microbes
Five stained leukocytes around a diagram dividing them into granulocytes and agranulocytes.
Granulocytes (neutrophil, eosinophil, basophil) above the line; agranulocytes (lymphocyte, monocyte) below. On the smear comparison of slide 16, the plasma cell is not a normal constituent of peripheral blood and is shown only for comparison. Lecture 8 · Slide 17

Telling the lymphocytes apart (slides 21 and 34)

T cellsB cellsNatural killer cells
OriginAll from hematopoietic stem cells
MaturationThymusBone marrowBone marrow and other tissues
Peripheral sitesLymph-node paracortex, splenic white pulp, mucosal lymphoid tissueLymph-node follicles, spleen, mucosal lymphoid tissueBlood and tissues
Immune roleAdaptive cellularAdaptive humoralInnate cytotoxic
PopulationsCD4 helper, CD8 cytotoxic, regulatory, memoryPlasma cells, memory B cellsCD56 bright and CD56 dim
ProductsCytokines such as IL-2 (interleukin-2) and IFN-γ (interferon gamma); cytotoxic granulesImmunoglobulins from plasma cells; cytokinesPerforin, granzymes, cytokines
Antigen receptorT-cell receptorSurface immunoglobulinActivating and inhibitory innate receptors
MemoryMemory T cellsMemory B cellsNo conventional B- or T-cell-type memory
MarkersCD3; CD4 or CD8 on the major subsetsCD19 and CD20 on many B cellsCD56; CD16 on many
Surface immunoglobulinAbsentPresent; lost with plasma-cell differentiationAbsent

8.4 · Objectives f & g — Antigens, and how they start a response

There is no antigen slide as such; these are the deck’s antigen facts, gathered.

  • What is recognized: adaptive B-cell and T-cell receptors recognize particular epitopes; innate receptors recognize patterns shared by groups of organisms (slide 10). Each antibody pairs with a compatible antigen shape (slide 40).
  • Types of antigen on the antibody-effects diagram (slide 58): soluble toxin molecules, viruses and bacteria; the virus and bacterium carry antigenic determinants on their surface. The type decides what antibody binding achieves (section 8.8).
  • Starting a response: exposure to the antigen initiates the antigen-dependent phase of B-cell maturation, in which the B cell differentiates into a plasma cell producing specific antibody (slide 22); the antigen selects the matching B cell from the repertoire and drives its clonal expansion (slide 23).
  • Presentation to T cells: helper T cells recognize antigenic peptides presented by major histocompatibility complex class II; cytotoxic T cells recognize peptides on class I (slides 30–31).

8.5 · Objective h — Primary and secondary response

Primary response (slide 35)Secondary response (slide 36)
WhenAfter the first exposure to an antigenAfter re-exposure
Speed and sizeAntibody production develops over days; timing and magnitude depend on the antigen and hostMemory cells support a generally faster and stronger response
Antibody classIgM rises first; IgG later and lowerClass-switched antibodies, often IgG, may reach higher levels and persist longer
MemoryMemory cells develop during this responseMemory cells drive it
Two graphs of antibody amount against days after first and second antigen exposure, with IgM and IgG curves.
First exposure: IgM peaks first (around day 10), IgG follows lower. Second exposure: IgG rises fast and high and stays up; IgM is a small bump. ★ High IgM suggests a first exposure; low IgM with high IgG suggests an earlier one. Lecture 8 · Slide 37

8.6 · Objective i — The B lymphocyte and its metamorphosis into the plasma cell

Humoral immunity uses antibodies; B cells are transformed into plasma cells, the actual antibody-producing cells (slide 22). B-cell maturation has two phases:

  1. Antigen-independent phase: expression of surface IgM.
  2. Antigen-dependent phase: differentiation of the B cell into a plasma cell producing specific antibodies. Exposure to the antigen initiates this phase.

Helper (CD4) T cells support it: helper signals support B-cell differentiation and antibody production, while plasma cells do the secreting (slide 24). B cells mature in the bone marrow and lose surface immunoglobulin when they become plasma cells (slide 34).

Antigen selecting one B cell from a repertoire, which divides by clonal expansion into plasma cells secreting antibody and memory cells.
The antigen selects the one B cell in the repertoire whose receptor fits; it becomes a B lymphoblast and divides (clonal expansion) into plasma cells secreting antibody molecules and memory cells. Lecture 8 · Slide 23

8.7 · Objectives j & k — Antibodies (immunoglobulins) and their morphology

Electrophoresis (slide 38) separates serum proteins in an electric field into albumin (nearest the positive pole) and the alpha, beta and gamma globulin fractions (gamma nearest the negative pole). Immunofixation characterizes immunoglobulin heavy- and light-chain types.

Immunoglobulins (slide 39) contribute to plasma proteins in variable proportions and are present in blood, tissue fluid and secretions. A basic antibody unit has two heavy chains and two light chains. Light chains are either kappa or lambda; each light chain has a variable and a constant region. The heavy- and light-chain variable regions jointly form the antigen-binding site.

Part (slides 41–43)What it is
Heavy-chain constant regionDetermines the immunoglobulin class (heavy chain μ, δ, γ, ε or α). IgG heavy chains have three constant domains; the number varies by class.
Disulfide bondsConnect the chains and support the structure
FabThe antigen-binding regions and the adjacent constant domains
FcHeavy-chain constant regions involved in effector functions; the complement-binding site sits on CH2
Papain cleavageCuts IgG at the hinge into two Fab fragments and the Fc
Labeled diagram of an antibody: heavy and light chains with variable and constant domains, Fab and Fc fragments, hinge region, disulfide bonds and complement-binding site.
Two heavy chains (VH, CH1, CH2, CH3) and two light chains (VL, CL) joined by disulfide (SS) bonds. The antigen-binding site is where VH meets VL; the Fab fragment is the arm, the Fc fragment the stem, joined at the hinge; the complement-binding site lies on CH2. Lecture 8 · Slide 42

The five classes (slides 44–46)

ClassApprox. share of serumStructureWhere and what
IgM5–10% (80–170 mg/dL)Secreted as a pentamer with a J chain; a monomer on the B-cell surfaceOften the first class secreted in a new response; agglutination (the pentamer places many binding sites on one molecule, linking antigen-bearing particles into clumps) and efficient classical complement activation; B-cell antigen receptor
IgG75–80% (700–1700 mg/dL)Monomer; four subclassesSerum and tissue fluid; crosses the placenta; prominent in secondary responses; neutralization, opsonization, maternal protection; complement activation varies by subclass
IgA10–15% (170–280 mg/dL)Mainly monomeric in serum; secretory IgA usually a dimer with a J chain and secretory componentSaliva, tears, colostrum; neutralization and prevention of microbial attachment at mucosal surfaces
IgDLess than 1%MonomerWith IgM on many mature naive B cells; part of the B-cell antigen-receptor system
IgELess than 1%Monomer binding high-affinity cell receptorsBound to mast cells and basophils; immediate allergic reactions including IgE-mediated anaphylaxis; defense against some parasites

The serum values are approximate adult comparisons; reference intervals vary by laboratory and method (slide 46).

Drawings of IgE, IgG and IgD monomers, secretory IgA dimer with J chain and secretory piece, and IgM pentamer with J chain.
IgE, IgG and IgD are monomers; secretory IgA is a dimer with J chain and secretory piece; secreted IgM is a pentamer with a J chain. Lecture 8 · Slide 45

8.8 · Objective l — What antibodies do, and how they destroy antigens

Function (slides 47–59)Mechanism
AgglutinationClumping: varying amounts of immunoglobulin join varying amounts of antigen; if the antigens are on a cell’s surface, agglutination occurs. Agglutination is listed as a main function of IgM (slide 46).
NeutralizationAntibody binding blocks an essential interaction with a host cell: it can prevent viral attachment or entry, or stop a toxin reaching or acting on its target. It limits activity without requiring physical destruction. ★
LysisDestruction of the cell, by incorporation with the complement system
PrecipitationAntibodies cross-link soluble antigens into larger complexes that can become insoluble and precipitate; complex formation may help phagocytes clear them
OpsonizationAntibody joins antigen on a cell’s surface, and this coating facilitates ingestion by a phagocyte

Orientation matters (slide 56): on an antibody-coated infected cell, the antigen-binding ends hold the cell and the Fc region faces outward to the responding cell. Natural killer cells perform antibody-dependent cellular cytotoxicity: their CD16 binds the Fc region of IgG coating a target cell (slide 32).

Six panels: bacterial cell tagged with antibodies, opsonization, neutralization, agglutination, complement fixation and precipitation.
“Produced antibodies bind antigens and stop their destructive behavior in one of several ways”: tagging, opsonization, neutralization, agglutination, complement fixation (lysis) and precipitation. On slide 58 the antigen type decides the effect: a soluble toxin is neutralized and precipitated, a virus neutralized and agglutinated, a bacterium opsonized. Lecture 8 · Slide 59

ABO red-cell compatibility (slide 49)

RecipientRed-cell antigensUsual plasma antibodiesCompatible donor red cells
ONeither A nor BAnti-A and anti-BO only
AAAnti-BO, A
BBAnti-AO, B
ABA and BNeitherO, A, B, AB

Every other pairing agglutinates. This is the ABO red-cell comparison only: Rh status, other antibodies and compatibility testing also matter, and plasma compatibility differs. ★ Group O red cells carry neither antigen, which is why the narration calls O the universal donor.

8.9 · Objectives m–p — Cellular immunity and the T lymphocytes

T cellRecognizesFunction
Helper T cell (CD4) (slides 24, 30)Antigenic peptides presented by major histocompatibility complex class II; activation needs appropriate recognition and additional signalsCoordinates cell-mediated and humoral responses through cytokines and cell contact; helper signals support B-cell differentiation and antibody production; IFN-γ (interferon gamma) promotes macrophage activation and antimicrobial activity
Cytotoxic T cell (CD8) (slides 25, 31)Antigenic peptides presented by major histocompatibility complex class IKills infected or malignant host cells: virus-infected, tumor and transplanted cells; perforin and granzymes trigger target-cell apoptosis
Regulatory T cell (slide 32)—Limits immune activation and maintains self-tolerance; many are CD4 cells expressing FOXP3
Memory T cell (slide 34)—Carries memory forward
★ “Four letters in help.” CD4 = helper, reading class II; CD8 = cytotoxic, reading class I (4 × 2 = 8 × 1). Natural killer cells, the third lymphocyte, need no specific antigen at all, and type IV hypersensitivity can use either CD4 or CD8 T cells (slide 31).

8.10 · Objectives q & r — Hypersensitivity and its four types

Hypersensitivity is when immune reactions, either humoral or cellular, result in injury to the body (slide 60). Four types are seen — and ★ the number names a mechanism, not a severity.

TypeMechanismExamples on the slides
I — anaphylactic, immediate (slides 61–62)A previous exposure sensitizes: IgE is produced and becomes fixed on mast cells and basophils. On re-exposure the antigen joins that surface antibody and mediators such as histamine are released. Local allergy (swelling, vasodilation); anaphylaxis, a rapid systemic reaction in which small exposures can cause severe disease: bronchospasm, laryngeal edema, hypotension; shock and skin findings are not required in every case. Triggers: drugs, insect venoms, other allergens.
II — cytotoxic, antibody-mediated (slide 63)IgG or IgM binds antigens on cells or within tissues; injury through phagocytosis, complement or antibody-dependent cellular cytotoxicity. Antibodies can also stimulate or block receptor function. ABO incompatibility; anti-GBM (anti-glomerular basement membrane) disease, which can cause glomerulonephritis and pulmonary hemorrhage
III — immune complex (slide 64)Antigen–antibody complexes deposit in tissues or vessel walls; complement and recruited inflammatory cells cause the injury Arthus reaction (local, previously sensitized person); serum sickness (systemic, circulating complexes); triggers include foreign proteins, drugs, biologic therapies; lupus, immune-complex glomerulonephritis or arthritis
IV — cell-mediated, delayed (slide 65)Sensitized CD4 or CD8 T cells; common delayed reactions develop over 24–72 hours; cytokines recruit and activate inflammatory cells, cytotoxic T cells injure targets directly; persistent stimulation can produce granulomas in particular settingsContact dermatitis, tuberculosis-related reactions, T-cell-mediated transplant rejection
II versus III is where the binding happens. In type II the antibody binds an antigen that is part of a cell or tissue; in type III antibody and antigen first form a complex, and the complex lodges somewhere to cause the damage.

8.11 · Objective s — The complement system

Complement (slide 66) is a network of circulating and cell-associated proteins and regulators. The liver produces many of the circulating components, many circulate as inactive precursors, and activation starts a regulated cascade. Its major functions (slide 67):

  • Opsonization: particulate antigens are coated with complement proteins (C3b) so phagocytosis happens easily and rapidly.
  • Inflammation: complement proteins cause vasodilation, letting more immune cells in, and some are chemotactic for neutrophils and macrophages (slide 69); C3a, C4a and C5a promote the inflammatory response (slide 75).
  • The membrane attack complex (slide 68): C5b initiates assembly of the terminal components C6–C9; the complex forms pores in a susceptible membrane (multiple C9 subunits make the channel, slide 73), disrupting ionic and osmotic balance; severe disruption causes lysis.
★ Pathway (slide 70)Starts when
ClassicalCommonly, C1 recognizes antigen-bound IgM or IgG (some activation is antibody-independent)
LectinRecognition proteins (mannose-binding lectin) bind microbial carbohydrates and activate associated proteases
AlternativeC3 activation and amplification on permissive surfaces, using factor B, factor D and properdin (slide 71)

All three pathways converge on C3 activation, then on C5, and C5b leads into the membrane attack complex.

Flow diagram of the lectin, classical and alternative complement pathways converging on C3b, then C5 and the membrane attack complex.
Lectin (MBL, mannose-binding lectin, with its proteases), classical (C1 → C4, C2) and alternative (C3, factor B, factor D, properdin) each build a C3 convertase; C3b then forms the C5 convertase, C5a is released, and C5b + C6–C9 make the membrane attack complex. Lecture 8 · Slide 71
Overview of complement: classical and alternative pathways cleaving C3 into C3a and C3b, leading to inflammation, opsonization by macrophages and the lytic pathway C5 to C9.
The three outcomes on one page: promotion of the inflammatory response (C4a, C3a, C5a: histamine release, attraction of phagocytes), opsonization (C3b coating for the macrophage) and the lytic pathway (C5–C9). ★ Lysis is only one of them. Lecture 8 · Slide 75

8.12 · Objectives t & u — Autoimmunity and autoimmune examples

No slide defines autoimmunity or is given to autoimmune disease. What the deck does say:

  • Self-tolerance is actively maintained: regulatory T cells limit immune activation and maintain self-tolerance (slide 32).
  • Antibody against self can act two ways in type II hypersensitivity: destroying the cell it binds, or stimulating or blocking a receptor without destroying it (slide 63).
  • Examples the deck names by mechanism: anti-GBM (anti-glomerular basement membrane) disease (type II, slide 63); lupus and immune-complex glomerulonephritis or arthritis (type III, slide 64).
  • Autoantibodies become more common with age, and clinical findings determine their significance (slide 77).

8.13 · Objectives v & w — Immunodeficiency, and the effect of age

Primary immunodeficiency (slide 76)Secondary immunodeficiency (slide 77)
WhatIntrinsic defects in immune development or function, often with a genetic basisReduced function from disease, medications, malignancy or inadequate nutrition
Primary disorder (slide 76)DefectConsequence
X-linked agammaglobulinemiaImpaired B-cell maturation, very low antibodiesRecurrent pyogenic bacterial infections
DiGeorge syndromeVariable impairment of thymic and T-cell development—
Severe combined immunodeficiencyProfound T-cell dysfunction with impaired B-cell immunityMay present in early infancy or be found by newborn screening

Age (slide 77)

  • Neonates: immunity still developing, protected by maternal IgG and milk-associated IgA; maternal antibody protection declines at rates that vary by antibody and exposure.
  • Older adults: changes in lymphocyte function and repertoire can reduce responses to new antigens; autoantibodies become more common, and clinical findings determine their significance.
Source: Immunity_Lecture_Recorded.pptx (narrated deck by Matthew Ward, DMSc, MBA, PA-C, 19 October 2026) and its per-slide narration. Figures are reproduced from the lecture slides and each is cited to its slide.

9 · Pulmonary Pathophysiology

Lecture 9 · 20 October 2026 · Matthew Ward, DMSc, MBA, PA-C (title slide: “Lecture modified & presented by”). No deck was posted. The 109 slides cited here are a rebuild from the two-part lecture video: last year’s deck in the order shown, plus the seven slides added this year (44, 51, 59, 64, 82, 98 and 103).

Instructional Objectives

  1. Review the anatomy of the pulmonary system
  2. Review the functions of the pulmonary system
  3. Describe the molecular mechanisms of pulmonary pathologies
  4. Compare and contrast the etiologies and pathophysiological processes of different pulmonary diseases, including:
    1. Acute respiratory failure
    2. Pulmonary hypertension
    3. Pulmonary malignancies
    4. Obstructive pulmonary diseases
    5. Restrictive pulmonary diseases
    6. Asthma
    7. Pulmonary edema
    8. Pulmonary embolism
    9. Cor pulmonale
The deck and the syllabus list the objectives differently. The deck’s objectives slide (slide 2) names five diseases (acute respiratory failure, pulmonary hypertension, malignancies, obstructive and restrictive disease) and adds “Briefly describe the PFT changes associated with varies type of obstructive and restrictive pulmonary diseases”. The list above is the syllabus verbatim. Three of its diseases have no section of their own in the deck: pulmonary edema, pulmonary embolism and cor pulmonale. Sections 9.9–9.11 gather what the slides say about each.

9.0 · What the lecture adds

The lecture ran 177 minutes in two video parts (1 hour 45 minutes and 1 hour 12 minutes), both transcribed in full and aligned to the slides; no second transcription exists for this video. The questions follow the minutes each slide was on screen:

Where the minutes wentMin
Acute respiratory failure (slides 6–14)19.7
Asthma (slides 35–44)14.6
Pleural effusion (slides 92–98)12.8
Emphysema and the obstructive pattern (slides 52–59)12.6
Pulmonary hypertension (slides 15–16, 20–23)11.3
Sarcoidosis, hypersensitivity pneumonitis, occupational disease (slides 75–81)9.1
Pneumonia (slides 104–109)9.1
Pneumothorax; chronic bronchitis9.0 each
Acute respiratory distress syndrome (slides 83–85)8.7

The lecturer narrates in full sentences and rarely flags a point. The few places he did:

★ Professor emphasized — stated in the lecture
SaidWhat it points at
“So, remember the names artery and vein are describing the direction of flow relative to the heart, not necessarily whether the blood is oxygenated or deoxygenated.” [part 1, 1:43]Slide 3: the pulmonary trunk and arteries carry deoxygenated blood to the alveoli (section 9.1).
“So the important clinical distinction is whether air, blood, or the membrane or the oxygen source is responsible.” [part 1, 19:21] The five mechanisms of hypoxic respiratory failure on slide 9 (section 9.3).
“The distinction between dead space and shunting is also important because dead space is ventilation with inadequate perfusion, while shunt is perfusion with inadequate ventilation.” [part 1, 23:11]Shunt sits under hypoxic failure (slide 9); increased dead space, “wasted ventilation”, under hypercapnic failure (slide 10).
“The key point is that a larger bronchial lumen is not automatically a healthier bronchus.” [part 1, 1:38:55]Bronchiectasis: the dilation comes from destroyed walls, and recovery from a flare does not restore the architecture (section 9.6).
“I’ll repeat, a tension pneumothorax is progressively getting worse that it not only affects our ventilation system but also our circulatory system.” [part 2, 39:11]Tension pneumothorax: air enters and cannot leave, pressure rises, the mediastinum shifts and venous return and cardiac output fall (section 9.7).
Caveats the lecturer added to the slides. Of asthma: “The word reversible is useful but needs context. Many patients have a strong reversible component while persistent inflammation and remodeling can produce less completely reversible limitation in some individuals.” [part 1, 57:33] (remodeling is on slide 43). Of the cancer doubling times: “The listed doubling time is approximate teaching figure, not reliable.” [part 1, 44:29]. Of the labels: “This slide uses the historical label blue bloater. It’s just shorthand” [part 1, 1:16:37], and pink puffer is “not a clinical description of every patient”. The slides’ figures and labels are still what the questions use. Slide slips: slide 95 prints the exudate protein cut-off as “>0.5mg/dl”; the lecturer corrected it in the recording: it is the pleural-to-serum protein ratio above one half, “not simply a protein one half milligram per deciliter” [part 2, 48:59].

9.1 · Objectives a & b — Anatomy and function of the pulmonary system

Pulmonary circulation (slide 3): deoxygenated blood leaves the right ventricle by the pulmonary trunk and pulmonary arteries to the capillaries around the alveoli. The normal pulmonary circulation is a high-flow, low-pressure system: about 22/8 to 25/8 mmHg, with a mean of 15 mmHg (slide 20).

Section of an alveolus with type I and type II pneumocytes, macrophage and capillaries, and an enlargement of the layers of the respiratory membrane.
The alveolus and the respiratory membrane. Type I pneumocytes form the thin alveolar wall; type II pneumocytes secrete surfactant; an alveolar macrophage sits in the air space. Oxygen and carbon dioxide diffuse across six thin layers: alveolar fluid with surfactant, alveolar epithelium, its basement membrane, the interstitial space, the capillary basement membrane and the capillary endothelium. Lecture 9 · Slide 4

Moving fluid across the capillary (slides 17–19)

Net filtration out of a capillary follows the Starling relation on slide 17: Jv = Kf[(Pc − Pif) − (πc − πif)]. Capillary hydrostatic pressure (Pc) and interstitial colloid osmotic pressure (πif) push fluid out; interstitial fluid pressure (Pif) and plasma colloid osmotic pressure (πc) hold it in.

Slide 18’s exampleHydrostatic pressureOsmotic pressureNet
Arterial end35 mm (larger)25 mm (smaller)10 mm out of the capillary into the tissues
Venous end15 mm (smaller)25 mm (larger)10 mm into the capillary

Hydrostatic pressure falls along the capillary while osmotic pressure stays about the same, so fluid filters out at one end and returns at the other. Lymphatic capillaries take up what is left.

Capillary from arteriole to venule with arrows for outward hydrostatic and inward osmotic forces at each end.
The same balance with a second set of numbers: at the arteriolar end an outward force of 41.3 mmHg against an inward osmotic 28 mmHg (net 13.3 mmHg out); at the venular end 21.3 mmHg out against 28 mmHg in (net 6.7 mmHg in). Lecture 9 · Slide 19

9.2 · Objective c — Molecular mechanisms of pulmonary pathologies

No slide is titled “molecular mechanisms”; these are the molecular steps the deck gives, disease by disease.

DiseaseMolecular mechanism
Allergic asthma (slide 39)IgE binds mast cells, which release histamine, leukotrienes (slow-reacting substances of anaphylaxis), prostaglandins, bradykinins, eosinophilic chemotactic factor and serotonin in response to antigen
Emphysema (slides 53–54)Proteolytic enzymes from neutrophils and macrophages destroy alveolar walls; smoking causes the inflammation that releases them and inactivates alpha-1 antitrypsin, the protective enzyme that inhibits proteolytic breakdown of alveolar tissue
Acute respiratory distress syndrome (slides 84–85)Acute lung injury activates the complement system and starts neutrophil sequestration in the lung; inflammatory deposition of proteins forms hyaline membranes; lack of surfactant lets alveoli collapse
Hypersensitivity pneumonitis (slide 79)Antibodies to inhaled particles form antigen–antibody complexes that deposit in the lung: a type III hypersensitivity reaction (cell-mediated immunity also contributes, per the lecturer)
Diffuse interstitial lung disease (slides 70, 73)An immune reaction to an initial injury of alveolar epithelial or capillary endothelial cells; fibroblasts lay down collagen
Sarcoidosis (slides 75–76)Alveolar macrophages activated by an unknown trigger; abnormal T-cell function

9.3 · Objective d.1 — Acute respiratory failure

Term (slide 7)Meaning
HypoxemiaDecreased blood oxygen: low arterial oxygen (PaO2) and low hemoglobin saturation, by arterial blood gas or pulse oximetry
HypoxiaDecreased tissue oxygenation
Acute respiratory failureDisturbed gas exchange with abnormal arterial blood gas values on room air (FiO2, fraction of inspired oxygen, 21%): PaO2 < 60 mmHg (hypoxemia), PaCO2 > 50 mmHg, pH < 7.30
Category (slides 8–10)What failsMechanisms
Hypoxic respiratory failureRespiration or oxygenation: hypoxemia with normal or low carbon dioxideVentilation/perfusion mismatch; shunt; decreased diffusion; alveolar hypoventilation; high altitude
Hypercapnic (hypercarbic) ventilatory failureVentilation: carbon dioxide is not removed, so it rises (hypercapnia); alveolar ventilation is inadequate for the carbon dioxide producedReduced alveolar ventilation or respiratory rate; inability to signal effector mechanisms (Guillain-Barré, spinal cord injury); increased dead space (wasted ventilation: hypovolemia, low cardiac output, pulmonary embolism); increased carbon dioxide production (fever, infection, trauma or burns); inability to sense a raised PaCO2 (drugs, alkalosis)
CombinedBoth respiratory and ventilatory failure—

★ Dead space against shunt (section 9.0): dead space is ventilation with inadequate perfusion (wasted ventilation, a hypercapnic mechanism); shunt is perfusion with inadequate ventilation (a hypoxic mechanism).

Causes of acute respiratory failure (slide 14)Examples
Central nervous systemSedatives, stroke, brain trauma or tumor
Neuromuscular diseaseMultiple sclerosis, myasthenia gravis, polio, Guillain-Barré syndrome, quadriplegia
Chest skeletal systemKyphoscoliosis, chest trauma, pleural effusion, massive ascites
AirwayLaryngospasm, foreign-body aspiration
Pulmonary parenchymaShock, pulmonary embolism, pulmonary edema, advanced emphysema, pneumonia, acute respiratory distress syndrome

Shown inside this section (slides 11–13): in acute lung injury, water, cells and protein leak into the tissue around the alveoli and cause large areas of alveoli to collapse, reducing the oxygen that reaches the blood (section 9.7 has the syndrome itself).

Normal alveolus beside an injured alveolus in the acute phase, with protein-rich edema fluid, hyaline membrane, neutrophils and a denuded basement membrane.
Normal alveolus (left) against the injured alveolus in the acute phase (right): protein-rich edema fluid, sloughed bronchial epithelium, necrotic type I cells, a denuded basement membrane, a hyaline membrane, inactivated surfactant and migrating neutrophils. Lecture 9 · Slide 12

9.4 · Objective d.2 — Pulmonary hypertension

The normal pulmonary circulation is high flow at low pressure (mean about 15 mmHg). Pulmonary hypertension is a mean pulmonary arterial pressure at rest > 20 mmHg (slide 20). The lecturer added that it “has to be measured by right heart catheterization” [part 1, 33:14] (said in the recording, not on a slide).

Type (slide 21)Features
IdiopathicCause unknown; rapidly progressive; more common in women; third to fourth decade
SecondaryResults from a known disease process
Route to pulmonary hypertension (slide 22)Examples
Increased pulmonary blood flow or viscosityLeft-to-right shunt (atrial septal defect, patent ductus arteriosus); polycythemia
Increased resistance to blood flowHypoxic vasoconstriction (chronic bronchitis, advanced emphysema); obstruction from embolism; pulmonary fibrosis
Increased left atrial pressureMitral stenosis, mitral regurgitation, left ventricular failure

Pathogenesis (slide 23): chronic exposure to the disease process changes the arterial lumen. The walls of the small pulmonary vessels thicken from more muscle mass in the media (local tissue hypoxia, acidosis); and the intima becomes fibrotic.

Normal and narrow pulmonary artery above a heart with an enlarged right ventricle.
A normal against a narrow pulmonary artery; the right ventricle pumping into it is enlarged (section 9.11). Lecture 9 · Slide 16

9.5 · Objective d.3 — Pulmonary malignancies

Carcinoma (slides 25–27)ShareWhereDoublingCharacter
Squamous cell (non-small cell)20–30%Central: two-thirds arise in central bronchi near the hilus, as intraluminal growthVolume in 100 days Sputum cytology can show it, so it is detected earlier than other lung cancers; spreads to regional lymph nodes
Adenocarcinoma35–40% (the largest share)Periphery; not as amenable to early detection180 daysAcinar, bronchoalveolar and papillary tumors; metastasizes to distant organs
Large cell5–10%Periphery, like adenocarcinomaAbout 100 daysLarge cells in nests or clusters; distant metastasis
Small cell (oat cell)15–20%Central bronchi, compressing and narrowing themAbout 33 days (fastest)Widespread metastasis common; the most resistant to therapy; paraneoplastic syndrome

The doubling times and shares are approximate teaching figures, not predictions for one patient (the lecturer’s caveat, section 9.0); the ranking is what to know.

9.6 · Objective d.4 — Obstructive pulmonary diseases

Obstructive diseases are manifested by increased airflow resistance (slide 33), from one of three places (slides 33–34):

Where the obstruction isDiseases
Conditions in the wall of the lumenAsthma, acute bronchitis, chronic bronchitis
Loss of lung parenchyma, or pressure around the outside of the airwayEmphysema; lymphadenopathy; tumor
Material in the airway lumenBronchiectasis, bronchiolitis, cystic fibrosis, acute tracheobronchial obstruction, epiglottitis, croup, foreign body

In chronic obstructive lung disease (slides 30–32), bronchioles narrow and block with mucus, alveoli are destroyed, and the lungs do not deflate like normal lungs because air is trapped in damaged air sacs.

Acute bronchitis (slides 45–47)

Acute inflammation of the trachea and bronchi. Causes: viral (influenza A or B, parainfluenza, respiratory syncytial virus, coronavirus, rhinovirus, coxsackievirus, adenovirus) or nonviral (Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma, Moraxella, Chlamydia pneumoniae; heat, smoke, irritant chemicals, allergy). The airways become inflamed and narrow with more mucus, loss of ciliary function and loss of parts of the ciliated epithelium. Microorganisms may leave a long-lasting hyperirritability with bronchospasm, so an improving cough can outlast the illness (slide 51).

Chronic bronchitis — type B, the “blue bloater” (slides 48–51)

  • Definition: hypersecretion of bronchial mucus with a chronic or recurrent productive cough for more than 3 months a year for 2 or more successive years; the obstruction is persistent and irreversible; age over 30–40.
  • Causes: cigarette smoking (90%), repeated airway infections, genetic predisposition, inhaled irritants.
  • Pathogenesis: chronic inflammation; mucosal swelling and fibrosis; hypertrophy of bronchial glands and goblet cells; thicker bronchial walls; neutrophil inflammation; mucus plus purulent exudate forms bronchial plugs; mucociliary clearance fails as ciliated columnar epithelium is replaced by squamous cells.
  • Consequences: high airflow resistance raises the work of breathing and oxygen demand; narrowing and plugs worsen V/Q (ventilation/perfusion) mismatch, giving hypoxemia and hypercarbia. “Blue bloater” reflects cyanosis and the edema of right-sided heart failure. Hypoxic vasoconstriction → pulmonary hypertension → right ventricular dilation (cor pulmonale) → right-sided failure.
  • A persistent productive cough describes a symptom pattern; airflow measurements establish whether obstruction goes with it (slide 51).

Emphysema — type A, the “pink puffer” (slides 53–59)

  • Definition: destruction of alveolar walls without fibrosis and abnormal enlargement of the distal air sacs; the slide states it is always associated with chronic bronchitis.
  • Causes: smoking (more than 70 pack-years is highly predictive), air pollution, alpha-1 antitrypsin deficiency (1%, hereditary).
  • Pathogenesis: proteolytic enzymes from neutrophils and macrophages destroy alveoli; smoking adds inflammation and inactivates alpha-1 antitrypsin. Lost elastic tissue narrows the smaller bronchioles; lost lung tissue removes the radial traction that holds the airways open, raising resistance and cutting airflow. Air is trapped, air sacs distend and bullae form.
Normal alveoli tightly packed around a bronchiole beside enlarged emphysematous air sacs around a narrowed, mucus-containing bronchiole.
Normal (A) against emphysema (B): enlarged air sacs with lost walls, and a narrowed bronchiole with mucus that no longer has surrounding tissue pulling it open. Lecture 9 · Slide 56
Emphysema type (slides 57–58)What it destroys
Centriacinar (centrilobular)The respiratory bronchioles; associated with chronic bronchitis
Panacinar (panlobular)The alveoli
ParaseptalThe peripheral lobules (alveolar ducts and sacs)
Normal acinus, centriacinar emphysema with distended respiratory bronchioles, and panacinar emphysema with enlarged alveoli.
Normal lung, centriacinar emphysema (distended respiratory bronchioles) and panacinar emphysema (the whole acinus, alveoli included, enlarged). Lecture 9 · Slide 58

The obstructive pattern on testing (slide 59)

  • A low FEV1/FVC (forced expiratory volume in 1 second to forced vital capacity) ratio identifies expiratory airflow limitation.
  • A high residual volume supports incomplete emptying.
  • A reduced DLCO (diffusing capacity for carbon monoxide) raises a separate gas-transfer question.

Restriction looks different: its confirming finding is a low total lung capacity (section 9.7).

Bronchiectasis (slides 60–64)

  • Destruction of bronchial walls dilates the bronchi: an obstructive, suppurative disorder. Congenital (50% related to cystic fibrosis) or acquired. Children are at higher risk: their soft, elastic bronchi are easily damaged by overinflation and by distention from inflammation or infection.
  • Pathogenesis: recurrent infection and inflammation of the bronchial walls; persistent dilation of medium-sized bronchi and bronchioles; destruction of central bronchial walls and obliteration of peripheral bronchi; H. influenzae is the most common bacterial cause; ciliated columnar epithelium turns squamous, pus forms. The dilated airways become pockets of infection, producing purulent, foul-smelling sputum.
  • Improvement in a flare does not restore the airway architecture (slide 64). ★ A larger bronchial lumen is not a healthier bronchus.
Bronchial tree with cylindrical, fusiform (varicose) and saccular dilatations, one containing mucus.
By shape (slide 62): cylindrical; saccular (cavity-like dilatations); and fusiform (varicose), a combination of saccular and cylindrical. Lecture 9 · Slide 63

9.7 · Objective d.5 — Restrictive pulmonary diseases

Restrictive diseases are manifested by decreased expansion of the lungs from changes in the parenchyma, pleura, chest wall or neuromuscular function (slide 66).

Group (slides 67–68)Disorders
Parenchyma: fibrotic interstitialDiffuse interstitial lung disease, sarcoidosis, hypersensitivity pneumonitis, occupational lung disease
Parenchyma: atelectaticAcute (adult) respiratory distress syndrome; infant respiratory distress syndrome
Pleural spacePneumothorax, pleural effusion
Neuromuscular, chest wall, obesityGuillain-Barré, myasthenia gravis, kyphoscoliosis, flail chest, obstructive sleep apnea
Infection or inflammationPneumonia, pulmonary tuberculosis, severe acute respiratory syndrome

On testing (slide 82): a low FVC alone does not establish restriction; a low total lung capacity confirms the restrictive pattern. Then separate stiff tissue from an external load or muscle weakness, using gas transfer, imaging and history.

Fibrotic interstitial lung diseases (slides 69–74)

Acute, subacute or chronic infiltration of alveolar walls by cells, fluid and connective tissue; untreated, the inflammation may progress to irreversible fibrosis. Diffuse interstitial lung disease is an immune-mediated disorder after an initial lung injury: it begins with injury to alveolar epithelial or capillary endothelial cells, thickens the interstitium and alveolar walls and adds collagen. Persistent alveolitis obliterates alveolar capillaries and ends in irreversible fibrosis, with large air-filled cysts.

Pattern in the alveoli (slides 72–74)What happens
1. InflammationEarly and reversible; more inflammatory cells, leakier membranes, fluid and debris in the alveoli
2. FibrosisFibroblasts proliferate and lay down large amounts of collagen; alveolar walls thicken
3. DestructionEnd stage: alveolar walls lost; excess fibrin deposition (slide 74) leaves stiff, noncompliant lungs. The lecturer added that established scar is excess fibrous matrix, collagen included, rather than fibrin alone; fibrin matters most in acute injury.
Sarcoidosis (slides 75–77)Hypersensitivity pneumonitis (slides 78–79)Occupational lung disease (slides 80–81)
CauseUnknown; alveolar macrophages activated by an unknown trigger; abnormal T-cell function. Acute form in the 20s–30s (women more than men); chronic form in the third to fourth decadeInhaled organic agents (wheat weevil, fungi, parakeet, pigeon, chicken); more common in nonsmokers; also called extrinsic allergic alveolitis (bird fancier’s, farmer’s, mushroom, cheese maker’s, fish-meat worker’s lung)Chronic inhalation of toxic gases or inert particles (coal, silica, asbestos; the lecturer added that the gases do not share one fibrotic pathway — carbon monoxide mainly impairs oxygen transport); pneumoconiosis = parenchymal disease from inhaled inorganic dust
LesionMultiple uniform noncaseating epithelioid granulomas (lymph nodes and lung most often; also skin, eyes, spleen, liver, kidney, bone marrow); asteroid bodiesAntibodies to the inhaled particles form type III immune complexes that deposit, causing inflammation and granulomas (slide 79; the lecturer added that cell-mediated immunity also plays an important role); thick alveolar walls, exudate, lymphocytes, plasma cells and eosinophils; fibrosis when advancedCiliary clearance fails; alveolar macrophages try to engulf the particles but fail; alveolar walls are damaged and the lung becomes fibrotic. Smoking and pollutants contribute by depressing ciliary function

Pneumoconiosis. A pneumoconiosis is parenchymal lung disease caused by inhalation of inorganic dust particles such as coal, silica and asbestos.

Acute respiratory distress syndrome (slides 83–85)

An atelectatic parenchymal disorder that occurs with other processes: shock, trauma (lung contusion, inhaled toxin), embolism, aspiration, drug overdose, radiation, disseminated intravascular coagulation; mortality 30–60%. The starting injury is damage to the alveolar-capillary membrane: permeability rises, the alveoli flood with proteinaceous fluid, and a protein-rich, noncardiogenic pulmonary edema develops; the injury activates complement and neutrophil sequestration. Three processes follow:

  • Noncardiogenic pulmonary edema from leaky pulmonary capillaries.
  • Atelectasis from lack of surfactant.
  • Hyaline membranes from inflammatory deposition of proteins. The slide files them under “fibrosis”; the lecturer stressed they are part of acute alveolar damage and should not simply be equated with mature chronic fibrosis [part 2, 31:30].

Pleural space: pneumothorax (slides 87–91)

The pleural space is a potential space holding only a little lubricating fluid; pneumothorax is air in it.

TypeWho and whyMechanism
Primary (spontaneous)Tall, thin men aged 20–40, no underlying disease; smoking raises the riskRupture of small subpleural blebs at the apices; air enters, the lung collapses and the rib cage springs out
SecondaryPreexisting lung disease: asthma, emphysema, cystic fibrosis, pneumonia, tuberculosisA complication of the disease, perhaps rupture of a cyst or bleb
TensionA pneumothorax leading to trapped air and increased pressure; results from penetrating or nonpenetrating injury (slide 89)Air enters but cannot escape during expiration, so pressure builds; the same-side lung collapses and the mediastinum is forced to the opposite side, reducing venous return and cardiac output
Spontaneous pneumothorax with a collapsed lung, and tension pneumothorax on inspiration and expiration with the mediastinum pushed across.
Spontaneous pneumothorax (top). Tension pneumothorax (bottom): air enters on inspiration and is held on expiration, so pressure builds and pushes the mediastinum across. Lecture 9 · Slide 91

Pleural space: pleural effusion (slides 92–98)

Not a disease but a collection of fluid or pus from another process; the normal pleural space holds 5–15 mL of serous fluid, made by parietal pleural capillaries and reabsorbed by parietal lymphatics. It forms from (slide 93) raised hydrostatic pressure (heart failure, portal hypertension), lowered plasma oncotic pressure (severe hypoalbuminemia, nephrotic syndrome, cirrhosis), or lowered pleural pressure (lung collapse).

Said in the recording, not on a slide (no question uses it): an effusion develops when fluid entry increases, removal decreases, or both [part 2, 43:47].

Transudate (slide 94)Exudate (slide 95)
ProteinLow: pleural/serum ratio < 0.5High: ratio > 0.5
LDH (lactate dehydrogenase)Pleural/serum ratio < 0.6Ratio > 0.6
Specific gravity< 1.016 (the lecturer called specific gravity an older approach, not the main basis of classification today)—
MechanismIncreased hydrostatic or decreased oncotic pressureMore fluid from increased pleural permeability (inflammation) or impaired lymphatic drainage
Associated withSevere heart failure, cirrhosis with ascites, nephrotic syndrome, myxedemaMalignancy, infection, pulmonary embolism, sarcoidosis, post-myocardial infarction syndrome, pancreatic disease

Exudate causes. Exudative pleural effusions are associated with malignancies, infections, pulmonary embolism, sarcoidosis, post-myocardial infarction syndrome and pancreatic disease.

What makes an effusion transudative. Transudates are caused by increased hydrostatic or decreased oncotic pressure, as in severe heart failure, cirrhosis with ascites, nephrotic syndrome and myxedema.

One positive criterion supports an exudate (Light’s criteria, as the lecturer named them; slide 98, worked through: a protein ratio of 0.42 is transudate-range, but an LDH ratio of 0.75 meets the exudate criterion, so the fluid is an exudate; pleural LDH above two-thirds of the serum upper limit of normal is the third criterion).

  • Hemothorax: blood mixed with pleural fluid (slide 96).
  • Chylothorax: a chylous exudate from leakage of chyle from the thoracic duct, after trauma or mediastinal malignancy such as lymphoma (slide 96).
Three tubes of pleural fluid: blood-stained, milky chylous, and pale yellow transudate.
A Blood-stained aspirate (pleural metastases from breast carcinoma). B Chylous effusion (bronchial carcinoma invading and obstructing the thoracic duct). C Pale transudate, typical of heart failure or generalized edema. Lecture 9 · Slide 97

Obstructive sleep apnea-hypopnea syndrome (slides 99–103)

Listed under the neuromuscular, chest wall and obesity disorders. A chronic condition of cyclic upper-airway obstruction during sleep with symptoms or signs of disturbed sleep; at least 5 obstructive events per hour is the minimal criterion. The collapsible segments of the pharynx close completely or partly.

EventAirflowEffort
Obstructive apneaAbsent for at least 10 secondsContinues
HypopneaA discrete decrease (not cessation) for at least 10 seconds, with oxygen desaturation or an abrupt arousal—
Central event (slide 103)AbsentAbsent

Each obstruction combines progressive asphyxia (too little oxygen, too much carbon dioxide) with sudden autonomic and behavioral arousal, causing acute cardiac and cerebrovascular disturbances.

Said in the recording, not on a slide (no question uses it): the return of airflow can bring a burst of sympathetic activity, with abrupt changes in heart rate, vascular tone and blood pressure [part 2, 61:07].

Pneumonia (slides 105–109)

  • An inflammatory reaction in the alveoli and interstitium caused by an infectious agent. Sources: aspiration of oropharyngeal secretions or gastric contents (gross aspiration delivers large numbers of anaerobic bacteria, a major factor in anaerobic infection and abscess); inhalation (virus, Mycoplasma); contamination from the systemic circulation (staphylococcal sepsis, right-sided endocarditis, intravenous drug use, gram-negative bacteremia).
  • Normal defenses are immune responses, cough, sneezing and mucociliary clearance; community-acquired pneumonia occurs when they are compromised. Organisms multiply, alveolar spaces fill with exudate, and the exudate consolidates, becoming hard to expectorate.
  • Community-acquired: a person living independently, or hospitalized for another reason for under 48 hours before respiratory symptoms; commonest typical pathogens S. pneumoniae, H. influenzae, Moraxella catarrhalis.
  • Hospital-acquired (and ventilator-associated): early onset (first 4 hospital days) tends to be antibiotic-susceptible bacteria; late onset is more often multidrug-resistant, with greater morbidity and mortality; aerobic gram-negative bacilli (Pseudomonas aeruginosa, E. coli, K. pneumoniae, Acinetobacter), S. aureus, H. influenzae.

9.8 · Objective d.6 — Asthma

Asthma is the obstructive airway disease that is reversible, with airway inflammation and increased airway responsiveness to a variety of stimuli (slide 35). The lecturer’s caveat (section 9.0): many patients have a strong reversible component, but persistent inflammation and remodeling can leave limitation that is less completely reversible.

Allergic (extrinsic) asthma (slide 39)Non-allergic (intrinsic) asthma (slide 37)
TriggerSpecific antigensExercise, stress, pulmonary irritants; aspirin and occupational allergens; no specific allergen identified
MechanismImmediate phase mediated by IgE: IgE on mast cells releases chemical mediators (histamine, leukotrienes — the slow-reacting substances of anaphylaxis — prostaglandins, bradykinins, eosinophilic chemotactic factor, serotonin)Negative skin tests to common inhalant allergens, normal serum IgE
Course—Often develops in middle age; less favorable prognosis

What sets asthma apart. Asthma is an obstructive airway disease whose obstruction is reversible, with airway inflammation and increased airway responsiveness to a variety of stimuli.

What happens to the airway (slides 40, 43): normal respiratory epithelium is denuded and replaced by goblet cells; microvascular permeability rises (mucosal edema, inflammatory exudate, bronchoconstriction); recruited leukocytes release more mediators that damage the epithelium; vagal stimulation adds mucus hypersecretion and bronchoconstriction. Immunohistopathology: denuded epithelium, collagen deposition beneath the basement membrane, edema, mast cell activation, infiltration by neutrophils, eosinophils and lymphocytes. The inflammation drives bronchospasm, mucosal edema, mucous plugs and airway wall remodeling.

Cross-sections of a normal airway and an asthmatic airway with thick mucus, mucosal edema, more mucous glands, hypertrophied muscle and a narrowed lumen.
Normal against asthmatic airway: thick mucus in the airway, mucosal edema, more mucous glands, hypertrophied smooth muscle and a narrowed lumen. Lecture 9 · Slide 41

Over time (slide 44): symptoms fluctuate and testing may be normal between episodes; muscle contraction and inflammation change at different speeds, so early improvement may leave inflammation behind.

9.9 · Objective d.7 — Pulmonary edema

No section of the deck is given to pulmonary edema; the pieces are:

  • The forces (slides 17–19, section 9.1): fluid leaves a capillary when hydrostatic pressure exceeds the osmotic pull; a rise in capillary hydrostatic pressure, or a fall in plasma oncotic pressure, increases filtration (the same two mechanisms make a transudative pleural effusion, slide 93).
  • Leaky capillaries (slides 84–85): in acute respiratory distress syndrome the injured alveolar-capillary membrane floods the alveoli with protein-rich fluid, a noncardiogenic pulmonary edema; in acute lung injury, leaked water, cells and protein collapse alveoli (slide 11).
  • Pulmonary edema is listed among the parenchymal causes of acute respiratory failure (slide 14).

9.10 · Objective d.8 — Pulmonary embolism

No section of the deck is given to pulmonary embolism; the slides use it as a cause in five places:

  • Dead space (slide 10): embolism increases dead space (wasted ventilation), one route to hypercapnic ventilatory failure.
  • Acute respiratory failure (slide 14): a parenchymal cause.
  • Pulmonary hypertension (slide 22): obstruction from embolism increases resistance to blood flow.
  • Acute respiratory distress syndrome (slide 83): embolism is among its causes.
  • Pleural effusion (slide 95): pulmonary embolism is associated with an exudate.

9.11 · Objective d.9 — Cor pulmonale

Cor pulmonale is right ventricular dilation from lung disease (slide 50). The chain, from chronic bronchitis: hypoxia → pulmonary artery vasoconstriction → pulmonary hypertension → right ventricular dilation (cor pulmonale) → right-sided heart failure, whose edema is part of the “blue bloater” picture. The same hypoxic vasoconstriction in advanced emphysema is a route to pulmonary hypertension (slide 22), and the narrowed pulmonary arteries leave an enlarged right ventricle (slide 16).

One chain links three objectives. Hypoxic lung disease (d.4) → hypoxic vasoconstriction → pulmonary hypertension (d.2) → right ventricular dilation, cor pulmonale (d.9). Pulmonary embolism (d.8) reaches pulmonary hypertension by a different route: obstruction, not vasoconstriction.
Source: 9. Pulmonary Pathophysiology — Ward 2026, rebuilt from the lecture video of 20 October 2026 (no deck was posted), and that recording. Figures are reproduced from the lecture slides and each is cited to its slide.

10 · Pathophysiology of Blood Disorders

Lecture 10 · 10 November 2026 · Matthew Ward, DMSc, MBA, PA-C · deck “Pathophysiology of Blood Disorders SV Fall 2026” (51 slides).

Instructional Objectives

  1. Review the anatomy of the blood cells
  2. Review the functions of blood cells
  3. Describe the molecular mechanisms of blood disorders
  4. Compare and contrast the etiologies and pathophysiological processes of white blood cell disorders
  5. Describe the process of bone marrow neoplasia
  6. Describe the etiologies and pathophysiological processes of myeloproliferative syndromes
  7. Describe the etiologies and pathophysiological processes of myelodysplastic syndromes
  8. Discuss the etiologies and pathophysiological processes of red blood cell disorders
  9. Describe the etiologies and pathophysiological processes of coagulation disorders
  10. Discuss the etiologies and pathophysiological processes of platelet disorders

10.0 · What the lecture adds

The lecture ran 96 minutes in two recorded parts (slides 3–26, then 27–50). The questions follow the minutes spent on each topic, with the slides he flagged counted half again:

Where the minutes wentMin
Red-cell indices and morphology (slides 29–32)8.3
Leukemia: pathogenesis, counts, leukostasis (slides 19–22)7.9
B cells, V(D)J recombination and clonality (slides 14–17)7.3
Coagulation reactions and cascade (slides 42–44)7.1
Hemolytic anemia (slides 37–39)6.9
Anemia by size and marrow response (slides 33–34)6.2
Neutrophils, neutropenia and bands (slides 9–10)6.1
Lymphoid neoplasms and B/T development (slides 23–24)5.1
Platelet disorders (slides 49–50), covered “very quickly”1.6
★ Professor emphasized — stated in the lecture
SaidWhat it points at
“These are the only lab values that you guys should have memorized. Everything else, not super important for you guys to have memorized. Just remember the patho.” [part 1, 13:11]The neutropenia grades by absolute neutrophil count (slide 9, section 10.3).
“This is going to be important for you guys to know the different diagnoses here and how to differentiate between them.” [part 1, 30:32] Myelodysplastic neoplasms vs acute myeloid leukemia vs myeloproliferative neoplasms (slide 18, section 10.4).
“Definitely important to know this slide.” [part 1, 40:46]Lymphoid neoplasms by lineage and stage of maturation (slide 23, section 10.3).
“For this lecture, this is pathology, so focus more on how to distinguish between the diseases.” [part 2, 0:00] — and “always remember the words mature, precursor, differentiated, and attach them to the corresponding disease names.” [part 2, 4:03]Chronic lymphocytic leukemia = mature; acute lymphoblastic leukemia = precursor; plasma-cell myeloma = differentiated (slide 28).
“You guys need to know your cascade in addition to factor numbers know the factor names” … “Make sure you know thrombin generation” … “also know your co-factors” … “make sure you know your extrinsic, intrinsic, and how they differ.” [part 2, 38:03–43:08]Slides 43–44 (section 10.8).
“Definitely know this slide here.” [part 2, 46:11]Hemophilia A and B, von Willebrand disease, factor V Leiden and antiphospholipid syndrome (slide 46, section 10.8).
★ Said to go light on

The reference-interval table (slide 34): “you don’t need to memorize this” [part 2, 17:22]. Factor XIII: “you don’t need to know it” [part 2, 39:03].

Spoken slips; the slides are what is tested. Twice he said “essential throm­bo­cyto­penia” for the myeloproliferative neoplasm the slides print as essential thrombocythemia (a HIGH platelet count; slides 18 and 26). He also called the splenic destruction of spherocytes “intravascular”; the figure on slide 39 shows them destroyed by splenic macrophages, which is extravascular hemolysis. No slide was corrected in the recording. Not on any slide (so not asked): demargination, smudge cells in chronic lymphocytic leukemia, rouleaux in myeloma, ferritin and hepcidin, the hematocrit-is-three-times-hemoglobin rule.

10.1 · Objectives a & b — Blood and its cells

Blood composition (slide 3): adult blood volume is usually about 4–6 L. Whole blood is approximately 55% plasma and 45% formed elements. Plasma is approximately 90–92% water and carries electrolytes, nutrients, waste products and proteins; plasma proteins include albumin, globulins and clotting factors. Serum is the fluid remaining after blood has clotted.

Plasma share of whole blood. Whole blood is approximately 55 percent plasma and 45 percent formed elements, and plasma itself is about 90 to 92 percent water carrying electrolytes, nutrients, wastes and proteins.

Hematopoiesis (slide 4): most hematopoiesis occurs in the bone marrow. In the healthy adult, almost all hematopoiesis occurs in the axial skeleton, and proximal humerus and femur.

Marrow histology with medullary venous sinuses, stromal cells and osteoblast, beside a long-bone diagram of its arterial supply.
Bone marrow, where most hematopoiesis occurs: medullary venous sinuses, stromal cells and the bone's nutrient, metaphyseal and epiphyseal arteries. Lecture 10 · Slide 4
Lineage tree: multipotent stem cell to myeloid and lymphoid progenitors and their mature cells.
The simplified lineage model. The myeloid progenitor gives erythroid precursors (to erythrocytes), megakaryocytes (to platelets), granulocytes (neutrophils, eosinophils, basophils) and monocytes (to macrophages). The lymphoid progenitor gives B cells, T cells and natural killer cells. Lecture 10 · Slide 5

Leukocytes (slide 6), literally “white cells”, are primarily involved in self-defense. They can be characterized as granulocytes vs agranulocytes, phagocytes vs nonphagocytic cells, and myeloid vs lymphoid lineage. Alteration in number may be due to infection, malignancy or autoimmune causes. Plasma cells are generally not listed.

Table of normal white blood cell distribution as a percentage of the total leukocyte count.
Normal distribution: neutrophils 40 to 60%, lymphocytes 20 to 40%, monocytes 2 to 8%, eosinophils 1 to 4%, basophils 0.5 to 1% of the total leukocyte count. Lecture 10 · Slide 6
Cell (slides 9–15)FunctionOn the smear (slide pictures)
NeutrophilFirst responder to infection; with macrophages, the phagocytic leukocytesSegmented nucleus (slide 9)
Band neutrophilImmature neutrophilKidney bean shaped nucleus with mature chromatin and no nucleoli; indentation greater than 1/2 diameter; secondary granules only
MonocytePrecursors to macrophagesKidney shaped nucleus with mature chromatin; vacuoles commonly noted; low nuclear-to-cytoplasmic ratio
EosinophilAllergy, parasites, drug effectNucleus with two lobes; eosinophilic (red) secondary granules; low nuclear-to-cytoplasmic ratio
BasophilParasite response and allergy; binds IgE (immunoglobulin E) Mature nucleus has 2–3 lobes, may be obscured by numerous basophilic secondary granules
LymphocyteB cells, T cells, natural killer cellsSlightly larger than a mature red cell; high nuclear-to-cytoplasmic ratio; round mature nucleus with clumped chromatin; scant, light blue cytoplasm with no granules
B cellProduces antibodies; selected cells become plasma cells or memory B cells —
Labeled drawing of a band neutrophil.
Band neutrophil: kidney-bean nucleus indented more than half its diameter, mature chromatin, no nucleoli, secondary granules only. Lecture 10 · Slide 10
Labeled drawing of an eosinophil.
Eosinophil: nucleus with two lobes, eosinophilic secondary granules, low nuclear-to-cytoplasmic ratio. Lecture 10 · Slide 12
Labeled drawing of a basophil.
Basophil: mature nucleus of 2 to 3 lobes, often obscured by numerous basophilic secondary granules. Lecture 10 · Slide 13
Labeled drawing of a lymphocyte.
Lymphocyte: high nuclear-to-cytoplasmic ratio, round nucleus with clumped chromatin, scant light blue cytoplasm with no granules. Lecture 10 · Slide 14
Labeled drawing of a monocyte.
Monocyte: kidney-shaped nucleus with mature chromatin, vacuoles commonly noted, low nuclear-to-cytoplasmic ratio. Lecture 10 · Slide 11

10.2 · Objective c — Molecular mechanisms of blood disorders

No slide is titled “molecular mechanisms”; these are the molecular steps the deck gives.

StepMechanism
B-cell development (slide 15)B cells develop in bone marrow and rearrange immunoglobulin genes. V(D)J recombination: heavy chains use V, D and J. Light chains use V and J.
After antigen (slide 15)Antigen activation can induce somatic hypermutation and affinity maturation in germinal centers; selected cells differentiate into plasma cells or memory B cells.
Malignant transformation (slides 16–17)Acquired genetic changes can promote abnormal lymphoid growth. A clone is a cell population descended from a common progenitor; lymphoid malignancies often share a dominant receptor-gene rearrangement, which PCR (polymerase chain reaction) can detect.
Acute leukemia (slide 20)Acquired mutations in transcription factors, which regulate the differentiation of immature lymphoid or myeloid cells, give maturation arrest; other mutations allow tumor cells to proliferate in a growth factor–independent fashion.
Thrombophilia (slide 46)Factor V Leiden: a genetic mutation. Antiphospholipid syndrome: an autoimmune response.

Light chains in V(D)J recombination. Developing B cells rearrange their immunoglobulin genes in the marrow: heavy chains use V, D and J segments, while light chains use only V and J.

Somatic hypermutation. After antigen activation, B cells in germinal centers can undergo somatic hypermutation, and selection of the better-binding cells produces affinity maturation.

B-cell development from lymphoid stem cell through pro-B, pre-B, immature, mature and activated B cell to plasma and memory cells.
B-cell development: immunoglobulin gene rearrangement in the marrow, then antigen-driven activation to plasma cell or memory B cell. Lecture 10 · Slide 15
Gel and capillary electrophoresis profiles comparing a polyclonal smear with a clonal peak.
Clonality by PCR (polymerase chain reaction): a polyclonal population gives a spread of products, a clonal one a dominant peak. A clonal result alone does not establish malignancy: reactive or premalignant populations can also be clonal, so the result is interpreted with morphology, immunophenotype and clinical findings. Lecture 10 · Slide 16

10.3 · Objective d — White blood cell disorders

Reading the count (slides 7–8)

White cell counts may be relative or absolute; read both. An absolute decrease in one type may show an artificially increased relative count in another. To convert relative to absolute: WBC (white blood cell) count × relative count as a fraction (a count of 8,000 cells/µL with 25% neutrophils is 2,000 neutrophils/µL).

Cell populationIncreased countDecreased count
Total leukocytesLeukocytosisLeukopenia
LymphocytesLymphocytosisLymphocytopenia
PlateletsThrombocytosisThrombocytopenia

Converting a relative count to an absolute count. The absolute count is the white blood cell count times the relative count expressed as a fraction: a total of 8,000 cells/µL with 25 percent neutrophils gives 2,000 neutrophils/µL.

Why read both counts. Percentages are shares of one total, so an absolute decrease in one cell type can show an artificially increased relative count in another. Reading the absolute count shows whether that cell really rose.

Neutropenia: decreased absolute neutrophil count. Eosinophilia: increased eosinophil count. Agranulocytosis: profound neutropenia, absolute neutrophil count below 200 cells/µL. Pancytopenia: reduced red cells, white cells and platelets.

★ Neutrophils and neutropenia (slide 9)

Neutrophils are the first responders to infection; neutrophils and macrophages are phagocytic leukocytes. Neutrophilia often accompanies acute bacterial inflammation. Neutropenia is classified by absolute neutrophil count, the one set of numbers the lecturer said to memorize:

★ GradeAbsolute neutrophil count
Mild1,000–1,500 cells/µL
Moderate500–1,000 cells/µL
Severebelow 500 cells/µL
Agranulocytosisbelow 200 cells/µL

Severe neutropenia increases the risk of serious infection.

★ “Fifteen, ten, five, two.” Hundreds of cells per microliter, counting down: below 1,500 mild, below 1,000 moderate, below 500 severe, below 200 agranulocytosis.

Band neutrophils (slide 10) are immature neutrophils. Bandemia: increased immature neutrophils (left shift); it may accompany infection or other inflammatory stress. Historical SIRS (systemic inflammatory response syndrome) criterion: >10% immature bands. Sepsis-3: infection-associated, life-threatening organ dysfunction.

Blood smear with two segmented neutrophils among red cells.
Neutrophils on a peripheral smear. Lecture 10 · Slide 9

Monocytes, eosinophils and basophils (slides 11–13)

Raised countThink of
Monocytes (precursors to macrophages)Chronic myelomonocytic leukemia; autoimmune disorders (sometimes); chronic infections (e.g. cytomegalovirus, tuberculosis)
EosinophilsThree things: allergy (especially asthma), parasite, drug effect; can rarely be neoplastic or autoimmune
BasophilsInvolved in parasite response and allergy; bind IgE (immunoglobulin E); really shouldn’t see many on a CBC (complete blood count); consider malignancy if elevated

★ Lymphoid neoplasms (slides 23, 24, 28)

Classification uses cell lineage and stage of maturation.

Cell of originNeoplasmThe word to attach
Precursor B or T cells (lymphoblasts)Acute lymphoblastic leukemia/lymphoma (B-ALL/LBL from the B-cell precursor in the marrow, T-ALL/LBL from the T-cell precursor in the thymus)Precursor
Mature B cellsChronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and other B-cell lymphomasMature
Mature T and natural killer cellsDistinct T-cell and NK-cell neoplasmsMature
Germinal-center B cellsClassic Hodgkin lymphoma—
Differentiated antibody-producing B-lineage cellsPlasma-cell myeloma Differentiated
Diagram: stem cell to lymphoid progenitor, then B-cell precursor in bone marrow and T-cell precursor in thymus, to mature cells.
B- and T-cell development. The B-cell precursor develops in the bone marrow (origin of B-ALL/LBL) and the T-cell precursor in the thymus (origin of T-ALL/LBL). Mature naive B cells undergo antigen activation and selection to plasma cells or memory B cells; mature T cells are CD4 or CD8. Lecture 10 · Slide 24

10.4 · Objective e — Bone marrow neoplasia

★ The three bone marrow neoplasms (slide 18)

Myelodysplastic neoplasms (MDS)Acute myeloid leukemia (AML)Myeloproliferative neoplasms (MPN)
Ineffective hematopoiesis with cytopenias and dysplasia. MDS can progress to AML. Myeloid malignancy with impaired differentiation and abnormal blast proliferation. Distinct from MDS. Clonal proliferation of myeloid cells. CML (chronic myeloid leukemia), polycythemia vera, essential thrombocythemia and primary myelofibrosis. Myelofibrosis can cause cytopenias.

WHO (World Health Organization): “myelodysplastic neoplasms.” “Myelodysplastic syndromes” remains in use in other frameworks.

Dys-, pro-, and blasts. Dysplastic = cells made badly (too few work); proliferative = too many made by a clone; acute leukemia = blasts that never grow up.

Leukemia (slides 19–22)

Leukemia: malignant cells in blood and bone marrow. The primary pathogenic defect in acute leukemia is maturation arrest. Acquired mutations in transcription factors block differentiation; other mutations let tumor cells proliferate growth factor–independently. These immature, malignant cells are called “lymphoblasts” or “myeloblasts” depending on the lineage.

Counts (slide 22): the peripheral WBC count may be low, normal or high. Marrow involvement can suppress normal blood-cell production and cause cytopenias. Hyperleukocytosis = a markedly elevated circulating white count. Leukostasis = impaired microcirculation with organ injury, often involving the lungs or brain. A high WBC count alone does not establish leukostasis.

Risk factors (slide 25) for hematologic neoplasms include exposure to chemical, viral and radiation mutagens and immunodeficiency disorders. The consequence: insufficient production of normal WBC, RBC, platelets (white cells, red cells and platelets).

Figure dividing hematologic neoplasms into lymphoid and myeloid lineages by cell of origin.
Neoplasms by lineage. Lymphoid: NK-cell, B-cell (leukemia/lymphoma/myeloma) and T-cell neoplasms. Myeloid: granulocytic and monocytic leukemia; red cell → polycythemia vera / erythroid leukemia; megakaryocyte → essential thrombocythemia / megakaryocytic leukemia. Lecture 10 · Slide 26

Multiple myeloma (slides 27–28)

  • Clonal plasma-cell malignancy involving the bone marrow — a malignancy of differentiated, antibody-producing B-lineage cells.
  • Multiple myeloma's cell of origin. Multiple myeloma is a clonal plasma-cell malignancy involving the bone marrow: a malignancy of differentiated, antibody-producing B-lineage cells.
  • Monoclonal proteins and marrow infiltration can cause renal injury, anemia and impaired immunity.
  • Altered bone remodeling can produce osteolytic lesions and hypercalcemia.
  • Active myeloma requires a plasma-cell neoplasm plus a myeloma-defining event (SLiM-CRAB). Bone lesions are not required when another defining event is present.

10.5 · Objective f — Myeloproliferative syndromes

Myeloproliferative neoplasms are a clonal proliferation of myeloid cells: chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and primary myelofibrosis (slide 18). Polycythemia vera is a clonal myeloproliferative neoplasm raising red-cell mass (slide 41); on the lineage figure it arises from the red-cell line, and essential thrombocythemia from the megakaryocyte (slide 26). Myelofibrosis can cause cytopenias. Primary thrombocytosis is a clonal marrow disorder (slide 50).

10.6 · Objective g — Myelodysplastic syndromes

Myelodysplastic neoplasms (the WHO term; “myelodysplastic syndromes” elsewhere) show ineffective hematopoiesis with cytopenias and dysplasia, and they can progress to acute myeloid leukemia while remaining distinct from it (slide 18).

10.7 · Objective h — Red blood cell disorders

Red blood cell disorders (slide 29): anemia (of blood loss, hemolytic, of diminished erythropoiesis) and polycythemia.

Indices and morphology (slides 30–32)

Red cell shape is assessed through visual inspection of peripheral smears. Mean cell volume: the average volume of a red cell. Mean cell hemoglobin: the average content (mass) of hemoglobin per red cell. Mean cell hemoglobin concentration: the average concentration of hemoglobin in a given volume of packed red cells.

Morphologic characteristics that provide etiologic clues: red cell size (normocytic, microcytic or macrocytic), degree of hemoglobinization, reflected in the color of red cells (normochromic or hypochromic), and shape.

  • Microcytic hypochromic anemias are caused by disorders of hemoglobin synthesis.
  • Hypochromia. The degree of hemoglobinization is reflected in the color of red cells: normochromic or hypochromic. Hypochromic cells carry less hemoglobin, as in the microcytic hypochromic anemias of impaired hemoglobin synthesis.
  • Macrocytic anemias often stem from abnormalities that impair the maturation of erythroid precursors in the bone marrow.
  • Normochromic, normocytic anemias have diverse etiologies: characteristic abnormalities of red cell shape provide an important clue to the cause.

Anemia by size and marrow response (slide 33)

Microcytic — MCV (mean cell volume) <80 fL (femtoliters)Normocytic — 80–100 fLMacrocytic — >100 fL
Iron deficiency
Thalassemia
Inflammation (some cases)
Sideroblastic anemia
Blood loss or hemolysis
Inflammation or renal disease
Marrow failure or infiltration
Early iron deficiency
Megaloblastic: B12 or folate deficiency
Nonmegaloblastic: liver disease, alcohol, drugs or reticulocytosis

Early iron deficiency. Established iron deficiency is microcytic, but early iron deficiency is listed with the normocytic anemias (mean cell volume 80 to 100 fL, femtoliters), before the cells have shrunk.

Sideroblastic anemia. The microcytic group (mean cell volume below 80 fL, femtoliters) lists iron deficiency, thalassemia, inflammation in some cases, and sideroblastic anemia.

Marrow response: absolute reticulocytes or the reticulocyte production index. Low or inadequate response: reduced production, or an early/blunted response to loss or destruction. Increased response: blood loss, hemolysis or recovery. A rise usually takes several days.

Small = can’t fill it, big = can’t finish it. Microcytic cells can’t fill with hemoglobin (synthesis); macrocytic cells can’t finish maturing (precursor maturation).

Example adult reference intervals (slide 34; illustrative only, use the reporting laboratory’s ranges; “you don’t need to memorize this”): hemoglobin 13.6–17.2 g/dL men, 12.0–15.0 women; hematocrit 39–49% and 33–43%; reticulocytes 0.5–1.5%; MCV 80–100 fL; MCH 27–33 pg; MCHC 33–37 g/dL; RDW 11.5–14.5%.

Anemia (slide 35)

Anemia reduces the blood’s oxygen-carrying capacity. Define anemia primarily by hemoglobin below the cutoff for age, sex and pregnancy status. WHO 2024 (ages 15–65): Hb (hemoglobin) <13 g/dL in men and <12 g/dL in nonpregnant women. Hematocrit is the proportion of blood volume occupied by red cells and provides supporting information. Interpret hemoglobin and hematocrit in the context of plasma volume and the clinical presentation: a fall in plasma volume raises them without any change in red-cell mass (relative erythrocytosis, slide 41).

Defining anemia. Anemia reduces the blood's oxygen-carrying capacity, and it is defined primarily by hemoglobin below the cutoff for age, sex and pregnancy status; hematocrit only supports.

Blood loss anemia (slide 36): acute or chronic. Blood loss sits in the normocytic group and brings an increased reticulocyte response once the marrow has had several days.

Hemolytic anemia (slides 37–39)

  • Red-cell survival is shortened below the usual lifespan of about 120 days.
  • Hemoglobin breakdown products increase as red cells are destroyed.
  • Erythropoietin and reticulocyte production usually increase when the marrow can compensate.
  • The reticulocyte response may be inadequate with marrow disease, nutrient deficiency, renal disease or infection.

The physiologic destruction of old red cells takes place within macrophages of the spleen, liver and bone marrow, triggered by age-dependent changes in red cell surface proteins. In the majority of hemolytic anemias the premature destruction of red cells also occurs within phagocytes, an event referred to as extravascular hemolysis; intravascular hemolysis is the other route, destruction within the circulation. Hereditary spherocytosis is the example:

Sequence: biconcave young red cell, loss of membrane, rigid spherocyte, trapped in spleen, eaten by macrophage.
Hereditary spherocytosis: a biconcave young cell released from the marrow → loss of lipid membrane due to repeated passage through the spleen and circulation → rigid, inflexible spherocytes → trapped in the spleen → premature destruction by splenic macrophages (extravascular). Lecture 10 · Slide 39

Anemia of diminished erythropoiesis (slide 40)

Too little production rather than loss or destruction: megaloblastic anemia, vitamin B12 deficiency anemia, iron deficiency anemia and aplastic anemia.

Lose it, break it, or don’t make it. Blood loss, hemolysis, diminished erythropoiesis — the three mechanisms of anemia.

Polycythemia (slide 41)

TypeMechanism
Relative erythrocytosisReduced plasma volume without increased red-cell mass, such as dehydration
Absolute erythrocytosisIncreased red-cell mass
  Polycythemia veraA clonal myeloproliferative neoplasm
  Secondary erythrocytosisAn erythropoietic response to hypoxia, increased erythropoietin or other stimuli

Erythrocytosis usually presents with elevated hemoglobin and/or hematocrit.

10.8 · Objective i — Coagulation disorders

★ The key reactions (slides 43–44)

Four-row diagram of coagulation reactions: initiation, factor X activation, thrombin generation, fibrin formation.
Coagulation key reactions. Initiation: tissue factor + VIIa activates IX and X. Factor X activation: IXa + VIIIa. Thrombin generation: Xa + Va converts prothrombin (II) to thrombin (IIa). Fibrin formation: thrombin turns fibrinogen (I) into fibrin, and XIIIa crosslinks it. VIIIa and Va are cofactors. Ca²⁺ and phospholipid surfaces support complex assembly. Lecture 10 · Slide 43
★ Slide 44What it says
Physiologic initiationTissue factor–VIIa activates IX and X. External bleeding is not required.
Laboratory pathwaysPT (prothrombin time) assesses extrinsic (VII) and common factors. aPTT (activated partial thromboplastin time) assesses intrinsic (XII, XI, IX, VIII) and common factors.
Common pathwayX, V, II and I generate thrombin and fibrin. IXa–VIIIa activates X, and Xa–Va generates thrombin.
RegulationAntithrombin and activated protein C with protein S limit coagulation.
FibrinolysisPlasminogen becomes plasmin, which degrades fibrin — a separate process from regulation.

The common pathway. The common pathway is factors X, V, II and I, which generate thrombin and fibrin; both the PT (prothrombin time) and the aPTT (activated partial thromboplastin time) assess it.

★ “PT is extrinsic, PTT is intrinsic”: the shorter test has the one factor (VII); the longer test name has the longer list (XII, XI, IX, VIII). Both share the common pathway X, V, II, I — “10, 5, 2, 1”.

★ Disorders of the coagulation cascade (slide 46)

Bleeding disordersThrombophilia (excessive clotting)
Hemophilia A: factor VIII deficiency
Hemophilia B: factor IX deficiency
Von Willebrand disease: VWF (von Willebrand factor) supports platelet adhesion and carries/stabilizes factor VIII
Factor V Leiden: genetic mutation
Antiphospholipid syndrome: autoimmune response
A before B, 8 before 9. Hemophilia A is factor VIII, hemophilia B is factor IX; IXa and VIIIa are partners in the step that activates factor X.

10.9 · Objective j — Platelet disorders

Quantitative (slide 50)Qualitative
Thrombocytopenia: reduced marrow production; immune destruction, including ITP (immune thrombocytopenia); drug reactions, including immune HIT
Thrombocytosis: reactive — inflammation, infection or iron deficiency; primary — a clonal marrow disorder
Inherited: adhesion, aggregation, secretion
Acquired: external factors, systemic diseases

Immune heparin-induced thrombocytopenia (HIT): platelet activation causes thrombosis despite a falling count.

Source: Pathophysiology of Blood Disorders SV Fall 2026 (51 slides) and the recording of 10 November 2026. Figures are reproduced from the lecture slides and each is cited to its slide.